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Magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) 
are increasingly under investigation to explore their potential role in establishing 
effective evaluation methods for the procedure of tissue regeneration carried out in vitro, 
in vivo, and in disease diagnosis. To this end, there is a continuous pursuit of novel tools 
both in vitro and in vivo. For instance, there is a great need for the development and 
evaluation of an MR-compatible incubation system that enables simultaneous monitoring 
and culturing of cell and tissue constructs using MRI techniques. Such an imaging-
compatible incubation system eliminates exposing the culture to the risks of temperature 
shock, sample contamination, and handling/stress during evaluation tests. Samples, 
therefore, are not wasted, and can be implanted in animal models for following in vivo 
experiments. While in vitro tissue engineering studies allow for extraction of useful 
information, the experimental conditions cannot be truly replicated in the in vivo 
environment. Animal models, therefore, are critical to assess and characterize the 
regeneration of the engineered tissues. Furthermore, continuous observation of 
regenerating tissues using imaging modalities can lead to a decreased number of animals, 
where each animal acts as its own control.  
  
  
 
 
In an effort to develop a device to promote the role of MRI in tissue engineering, 
including extraction of leading biomarkers for in vitro studies, the e-incubator system 
was developed, which is an autonomous MRI-compatible incubation system. MRI was 
also applied in vivo on mouse models to show the potential of different MRI contrast 
mechanisms in characterizing tissue-engineered bone and cartilage. The engineered 
constructs were also imaged in vivo using MRE to characterize their stiffness changes. 
Furthermore, the role of MRE in diagnosis of nonalcoholic fatty liver disease (NAFLD) 
was investigated by monitoring the variations of liver stiffness followed by the analysis 
of changes in gene expression of fibrosis-specific genes in a mouse model. Altogether, 
this dissertation work showed the potential of MRI technologies in promoting tissue 
engineering and disease diagnosis through introducing the e-incubator system, providing 
noninvasive in vivo imaging markers for bone and cartilage regeneration, and describing 
MRE as an effective noninvasive method for early detection of NAFLD. 
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CHAPTER 1 
 
DISSERTATION OVERVIEW 
 
Motivation and Objectives 
Researchers have looked into the applications of imaging techniques that 
incorporate tomographic data to estimate the state of different layers inside a tissue 
culture. MRI scanning is one of the tomographic methodologies observing the growth 
and metabolic functions of cultured cells and constructs [1-3]. It can be utilized to 
determine the distribution of the cells inoculated in tissue-like constructs, global density, 
flow dynamics, and quality control in cell distribution [4]. MRI also provides great image 
quality, high spatial resolution, varied contrast-weighting, 3D-multiplanar capability, and 
is a noninvasive technique with non-ionizing radiation [5-7]. Furthermore, recent 
developments in MRI including high field MRI, more-sensitive RF coils and gradients, 
sophisticated pulse sequences, and innovative techniques open a horizon to the 
applications of MRI in disease diagnosis. MRI, in addition to determining morphologic 
and biological information, demonstrates the ability to assess mechanical properties of 
tissues. One recently developed technique for the measurement of shear stiffness via MRI 
is through a technique termed magnetic resonance elastography (MRE). Introduced by 
Muthupillai et al. in 1995, MRE is a phase contrast technique that obtains information 
about the stiffness of tissue by assessing the propagation of mechanical waves through 
the tissue with a special technique including: 1) generating shear waves in the tissue, 2) 
acquiring MR images depicting the propagation of the induced shear waves 3) processing 
the images of the shear waves to generate quantitative maps of tissue stiffness [8]. This 
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noninvasive technique received a great deal of attention because of higher signal-to-
noise-ratio (SNR), resolution and penetration depth compared with other elastography 
techniques like ultrasound elastography (UE), which allows volumetric mechanical 
imaging. Over the past two decades, MRE has been demonstrated in preliminary human 
studies as a diagnostic method for abnormalities in the breast, liver, kidney, prostate, 
brain, blood vessels, heart, and skeletal muscle. Also, MRE is currently used clinically 
for assessment of chronic liver diseases [8-11]. 
There is a great need for the development and evaluation of incubation systems 
that closely simulate in vivo conditions and enable observation of cell and tissue 
constructs using medical imaging technologies [12-15]. As compared to conventional 
tissue culture systems, an autonomous in vitro culture imaging platform allows 
monitoring and recording of the culture environment continuously. Such in vitro 
platforms are expected to play a fundamental role in studying potential strategies for the 
treatment of various diseases in humans, such as cancer [16, 17], and those associated 
with bone [18], cartilage [19], and heart [20] disorders. These impose more than $1200 
billion per year to the US healthcare system [21, 22]. In addition to the ex vivo 
investigation of the pathophysiology of diseases, such platforms also have potential 
applications in developments in regenerative medicine [23, 24], in drug delivery studies 
[25, 26], and in basic biological research [27]. There are a limited number of tools to 
noninvasively extract information concerning the cultured constructs without causing 
destructive changes to its structure. Imaging modalities are considered to be among the 
best validation methods. There is acceptance that modern medicine increasingly depends 
on imaging modalities such as MRI, computed tomography (CT), and positron emission 
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tomography (PET), as they can also be applied to tissue engineering studies (e.g. in tissue 
characterization to distinguish the changes in the cellular features of tissue constructs and 
efficiency improvement of the cell culture and its subsequent implantation) [28] and 
regenerative medicine (e.g. observing the changes in transplanted stem cells in animal 
models and in clinical trials) [29, 30]. Some of the known features which can be 
characterized by medical imaging modalities are anatomical [31], mechanical (elasticity 
and viscoelasticity) [32, 33], NMR (relaxation times, magnetization transfer, and 
chemical shift) [2, 34], and biological (apparent diffusion coefficient) [35]. 
Within this area, it is very important that the repeated imaging of a tissue 
construct is carried out in a noninvasive manner without harming the developing tissue. 
Most current systems do not provide a completely noninvasive way to characterize the 
culture; therefore, the samples are under risk of exposure to contamination, temperature 
shock, or handling difficulties from the incubation platform to the point where they are 
under assessment [2, 33, 36]. This highlights the need for an autonomous incubation 
system which could function in tandem with an imaging machine and could allow us to 
repeatedly visualize the variations in the structure and characteristics of the culture. 
Therefore, one objective of this dissertation work was to design a novel small-
scale, portable, autonomous system, known as the e-incubator, which would enable real-
time visualization of cultured tissue constructs or biological compounds in miniature 
sizes for different geometries and in a closed controlled environment. The design follows 
the need for a system with real-time tomographic imaging capability, which is enabled by 
integrating the platform with a high-field MRI system. All applied parts were designed 
and adapted to facilitate MRI imaging and to reduce MR signal loss.  
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TEB analysis in vivo relies heavily on tissue histological and end-point 
evaluations that require the sacrifice of animals at specific time points [37-40]. 
Unfortunately, due to differences in animal responses to implanted tissues, these 
conventional analytical methods to evaluate TEB can introduce data inconsistencies or 
scattering. Also and importantly, the current methods increase the number of animals 
needed to provide an acceptable statistical power for hypothesis testing. However, 
through the continuous analysis of regenerating tissue, noninvasive medical imaging can 
lead to decreased numbers of animals, where each animal acts as its own control [37, 41, 
42]. Therefore, a second objective of this dissertation work was to test the feasibility of 
multi-modal imaging techniques including MRI and near-infrared (NIR) optical imaging 
to visualize and quantify TEB. In a six-month feasibility study, TEB was implanted in a 
critical-sized calvarial defect mouse model. Osteogenesis of the TEB was monitored, 
through signal variation, using MRI and NIR. Histological endpoint measurements and 
computed tomography (CT) were used to confirm imaging findings. Taken together, 
results of this part of my research demonstrate the potential of multi-modal imaging to 
visualize and quantify TEB, which implies noninvasive techniques for assessment of 
regenerative medicine strategies. 
Although there are several studies that evaluate the in vivo growth of cartilage 
[43-47], there is still a lack of information about effective and sensitive imaging markers 
quantitated for cartilage tissue engineering. Such information is increasingly being used 
to study engineered tissue growth, development, and regeneration in vitro and in vivo. A 
third objective of this dissertation work is to characterize the biological and mechanical 
features of three cartilage constructs (silk, gelatin, and collagen) after implantation in an 
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11-week study. The results of this work will provide researchers with a noninvasive 
rapid-feedback method for improving the engineered outcome. This research will enable 
the design of better engineered cartilage tissue that can be translated into treatment of 
tissue defects.  
As a fourth objective of this dissertation, correlation of liver stiffness and fibrosis-
specific genes expression in the evaluation of nonalcoholic fatty liver disease was 
assessed. Two populations of mice, including one fed with a high fat diet and a control, 
were under study for four weeks. MRE measurements were performed at 9.4 T to map 
the liver tissue stiffness. The changes of liver genes expression between the two groups 
were also assessed at week four by transcription of mRNA followed by real time 
polymerase chain reaction. The outcome of this work helps to better diagnose 
nonalcoholic fatty liver disease prior to the clinical onset of obesity.  
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Dissertation Outline 
Chapter 2 Presents a background of MRI including the history, fundamental 
principles, the concept of relaxation, and pulse sequences.  
Chapter 3  Provides a background of tissue engineering / regenerative medicine, stem 
cells, mesenchymal stem cells, and bioreactors. An introduction to the need for imaging-
compatible incubation systems is provided as well. 
Chapter 4  Presents the design, validation experiments, and applications of the e-
incubator system, which is an MRI-compatible smart incubation system.  
Chapter 5  Investigates applications of multi-modal imaging systems including MRI, 
near infrared optical imaging, and CT for monitoring bone repair in a mouse critical-size 
calvarial defect model.  
Chapter 6  Evaluates the potential of MRI and MRE techniques to characterize the 
biological and mechanical features of various cartilage constructs using silk, gelatin, and 
collagen scaffolds after implantation in mice.  
Chapter 7  Assesses nonalcoholic fatty liver disease (NAFLD) by quantification of 
the liver stiffness and gene expression. MRE and real-time polymerase chain reaction are 
presented as the techniques used to quantitate the liver stiffness and the liver genes 
expression, respectively.  
Chapter 8  Summarizes the work presented in this dissertation, discussing 
conclusions and achievements. Recommendations for future work are also presented. 
7 
 
  
 
 
CHAPTER 2 
 
FUNDAMENTALS OF MAGNETIC RESONANCE IMAGING (MRI) 
 
2.1 The History of Magnetic Resonance Imaging 
In 1939 Rabi and his colleagues observed nuclear magnetic resonance (NMR) 
under a very high vacuum [48]. In their study, a beam of hydrogen molecules was sent 
through two different magnetic fields in which radio frequency (RF) [49] electromagnetic 
energy was applied to the molecules. The first one was homogeneous and the second one 
was inhomogeneous. This energy was absorbed by the molecular beam at a narrowly-
defined frequency and experienced a slight deflection. Following that, Purcell, Torrey 
and Pound at Harvard University, and Bloch, Hansen and Packard at Stanford University 
continued the research and discovered the nuclear magnetic resonance (NMR) within a 
few days of each other in 1945. The phenomenon of NMR in bulk materials, such as 
water and paraffin wax in their liquid state, were investigated. They presented the 
discovery in the same issue of Physical Review [50, 51]. Bloch and Purcell were awarded 
the 1952 Nobel Prize for physics in recognition of their innovative achievements. Over 
the following few years, the tight relation between the resonance frequency of a nucleus 
and the state of its chemical environment was shown by Knight in 1949 [52], Dickinson 
in 1950 [53], Lindstrom in 1950 [54], and Proctor and Yu in 1950 [55]. Later in 1951, 
Arnold, Dharmatti, and Packard found separate resonance lines for chemically different 
protons [56]. This was the onset of applications of NMR as the most used spectroscopic 
method in all branches of chemistry. The NMR spectrum in organic chemistry provides 
an important probe in structure identification and can be used by chemists to achieve 
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perception of molecular structures. The NMR technique also has applications for the 
identification of structural information of complex molecules with biological significance 
such as proteins and nucleic acids. In 1971, the potential of detection of tumors in vivo by 
NMR was reported by Damadian [57]. He showed tumors can be discriminated from the 
normal tissue because of much longer relaxation times. In 1973, Lauterbur incorporated 
the spatial information of protons for magnetic resonance imaging and successfully 
developed a technique to generate the first MR image in 2D and 3D from an NMR 
spectrometer using linear magnetic field gradients [58]. He employed the back-projection 
method to generate 2D NMR images which had already been used in computer-assisted 
tomography (CAT)-scan. Lauterbur published the first cross-sectional in vivo image of a 
mouse in 1974 [59]. Concurrent to Lauterbur, Mansfield was pursuing the development 
of a mathematical technique in the Department of Physics at the University of 
Nottingham. Mansfield and Grannell described the application of magnetic field 
gradients to achieve spatial data in NMR experiments [60]. Lauterbur and Mansfield 
were awarded the 2003 Nobel Prize in Physiology or Medicine for their findings 
concerning MRI. In 1975, Richard Ernst developed a way to reconstruct the 2D images 
from Fourier transform of phase and frequency encoding which is the basis of current 
MRI [61]. This method was reported that reconstructs an image from NMR signals more 
rapidly than Lauterbur’s back-projection. Ernst was awarded the 1991 Nobel Prize in 
Chemistry for his efforts in pulsed Fourier Transform NMR and MRI. The capacity of 
such an imaging technique to diagnose diseases such as cancer was quickly understood. 
During the past four decades, MR imaging and spectroscopy techniques have become 
advanced by more developments in superconducting magnets, computers, imaging 
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techniques, and reconstruction algorithms. Since then, MR imaging has drawn attractions 
to the scientific and clinical community due to the wide range of applications for 
noninvasive clinical studies of human anatomy and metabolism. For example the number 
of operational MRI worldwide increased from 3 in 1981 to more than 25000 in 2013 [62]. 
MR imaging techniques carry some advantages over other tomographic imaging 
techniques. MRI does not employ ionizing radiation like X-ray, CT, PET, or SPECT. 
MRI can penetrate bone without attenuation in contrast to ultrasound. It provides high 
resolution images of soft tissues without the use of contrast materials and allows greater 
sensitivity with contrast agents [63-65]. To sum it up, MRI has become a well-known 
clinical technique for detecting many pathological conditions and assessing metabolic 
functions.  
2.2 The fundamental principles of MRI 
When a nucleus has an odd number of protons or neutrons or both it will include a 
net magnetic dipole as well as a net angular momentum. In the case that the nucleus is 
exposed to an external magnetic field B0 (in this dissertation, vectors will be denoted by 
bold type letters), its magnetic moment precesses around the line parallel to the B0 as 
shown in Figure 2-1. Let’s define the direction of the B0 along the z-axis. Quantum 
mechanics indicates that the angular momentum and z-component of the magnet moment 
are quantized. A spin number can be assigned to every nucleus as the multiple of a half-
integer which can be positive or negative. The magnetic dipole moment of spins can be 
one of two possible states of m=½ and m=-½. Having the same levels of energy in the 
absence of an external magnetic field, spins show a different energy level while exposed 
to an external magnetic field. Each of the individual unpaired electrons, protons, and 
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neutrons has a spin of 1/2 or -1/2. When the number of protons is odd or the total number 
of protons plus neutrons for a nucleus is odd, it possesses spin. The spin of an individual 
nucleus creates a magnetic field and, as a result, a magnetic moment; therefore, the 
nucleus acts similar to a miniature magnet with north and south poles. 
 
Figure 2-1 Orientation and precession of a magnetic dipole in the presence of an 
external magnetic field (redrawn from figure 1.4, reference [66]). B0 aligned along 
the z-axis direction. B0 and M are bold which specify that they have magnitude and 
direction as a vector. 
The magnetic moment of a nucleus precesses at the Larmor frequency which is 
defined by the Larmor equation 
        (2.1) 
where ω is the Larmor frequency, B0 is the external magnetic field in Tesla, and γ is the 
gyromagnetic ratio. The gyromagnetic ratio is a specific number for each type of nucleus. 
Table 2-1 summarizes the net spin, gyromagnetic ratio, and natural abundance for 
multiple MR detectable nuclei (Only the nuclei with spin can be detected by NMR 
techniques) playing an important role in many physiological processes [67]. The largest 
11 
 
  
 
 
gyromagnetic ratio is 42.58 MHz/T and belongs to the hydrogen nucleus (
1
H); thus, 
hydrogen produces the strongest magnetic signal per atom. In addition, it is the most 
abundant nucleus in the body and is used in most imaging applications. Instead of dealing 
with the magnetic moment of a single nucleus, the net magnetic moment M is used. At an 
equilibrium condition the single magnetic dipoles precess at random phases; therefore, x 
and y components of M are zero. In another words M is parallel to the z-axis. 
Table 2-1 Net spin, gyromagnetic ratio, and natural abundance for common 
biologically relevant nuclei [67]. 
Nuclei Net spin Gyromagnetic 
ratio (MHz/T) 
% Natural 
Abundance 
1
H 1/2 42.58 99.98 
7
Li 3/2 16.55 92.58 
13
C 1/2 10.71 1.11 
15
N 1/2 4.31  0.36 
17
O 5/2 5.77 0.04 
19
F 1/2 40.05  100.00 
23
Na 3/2 11.26  100.00 
31
P 1/2 17.23  100.00 
25
Mg 5/2 2.61 10.13 
33
S 3/2 3.27 0.74 
35
Cl 3/2 4.17 75.53 
37
Cl 3/2 3.47 24.47 
39
K 3/2 1.99 93.10 
35
K 3/2 1.09 6.88 
43
Ca 7/2 2.86 0.15 
 
To investigate the NMR properties of a substance, a radiofrequency (RF) signal is 
applied to nuclei resulting in another magnetic field named B1 perpendicular to B0; 
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therefore, the distribution of 1/2 and -1/2 spins is disrupted and M is tipped into the x-y 
plane. The B1 magnetic field has to oscillate in the same resonance frequency of a 
nucleus to be able to tip its M; on the other hand, the Larmor frequency of 
1
H in a typical 
magnetic field is in the radio frequency range. Thus, the B1 magnetic field used to tip the 
net magnetic moment of a proton is achieved using an RF pulse. After applying the B1 
field, M tips to the x-y plane and keeps on precessing at the Larmor frequency. This is 
because, after applying the RF pulse, the magnetic moments of all nuclei precess 
together, not in a random manner. At a specific time after removing the RF pulse, M 
returns to its equilibrium direction parallel to the B0 because of entropy. This process is 
called relaxation. The net magnetization vector will rotate in a plane perpendicular to the 
applied B1 pulse and with an angle which is governed by the gyromagnetic ratio of the 
nucleus, the amplitude of the RF pulse (|B1|), and duration of the RF pulse. Figure 2-2 is 
an example of tipping the net magnetization vector by applying a 90˚ and 180˚ RF pulse. 
 
Figure 2-2 Rotation of the net magnetization vector M in a Cartesian coordination 
system rotating at Larmor frequency around z-axis (redrawn from figure 1.5, 
reference [66]). (a) Spin system at equilibrium in a stationary magnetic field B0. (b) 
After applying a 90 degree RF pulse the net magnetization vector tips to x-y plane. 
(c) Applying a 180 degree RF pulse will result in inversion of the net magnetization 
vector. 
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To summarize, when our body is placed in the strong magnetic field of an MRI 
system, the magnetic fields of its protons combine to configure a net magnetization 
vector. This vector is in the direction of the main magnetic field which is called 
longitudinal directions. The net magnetization vector starts rotating by absorption of RF 
energy which depends on the energy and duration of the RF signal. Two important RF 
pulses are 90˚ and 180˚ RF pulses which tip the net magnetization vector to the x-y plane 
and the z direction respectively. 
2.3 Relaxation 
Relaxation is the process by which the net magnetization of a nucleus returns to 
its equilibrium state after absorption of the RF signal. The net magnetization vector 
which is aligned along the z direction is called longitudinal magnetization. When this 
vector is tipped into the x-y plane, it is called transverse magnetization. T1 relaxation or 
longitudinal relaxation happens when the magnetization vector grows back in the 
longitudinal direction from zero to its thermal equilibrium value. T1 time is defined as the 
time of the longitudinal growth of the net magnetization to 63% of its final value after 
applying a 90˚ RF pulse as is described in Figure 2-3. Different tissues have different 
values of T1 relaxation time; therefore, T1 time is one of the main sources of contrast in 
MRI images.  
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Figure 2-3 T1 relaxation time demonstration (redrawn from figures 9 and 10, 
reference [68]).  (a) 90˚ RF pulse applied to tip the longitudinal magnetization vector 
to transverse plane. (b) The longitudinal magnetization vector becomes zero and 
then grows up in the z-axis direction. (c) T1 relaxation time for a tissue is defined as 
the time that the longitudinal magnetization grows back to 63% of its equilibrium 
value. 
 
Figure 2-4 (a) T1-weighted MRI image of a mouse brain acquired by a SEMS 
sequence. (b) T2-weighted MRI image of a mouse brain acquired by a SEMS 
sequence. 
Figures 2-4a and b show T1-weighted and T2-weighted MRI images of a mouse 
brain respectively. In a mouse brain, similar to a human brain, T1 time for white matter is 
shorter than gray matter. Also, T1 time for gray matter is shorter than cerebrospinal fluid 
(CSF). Therefore, white matter relaxes rapidly, CSF relaxes slowly, and gray matter 
relaxes at an intermediate rate. T1 relaxation curves for these three tissues are denoted in 
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Figure 2-5. To acquire a T1-weighted image, acquisition should take place at a time that 
these curves are widely separated. In a T1-weighted image, the pixels related to white 
matter are lighter, CSF is darker, and gray matter is at intermediate shades of gray. 
 
Figure 2-5 Different brain tissues have different T1 relaxation rates (redrawn from 
figure 11,  reference [68]). White matter has shorter T1 time than CSF. Gray matter 
has an intermediate T1 relaxation time compared with white matter and CSF. 
T2 relaxation time is another source of contrast in MRI images. By applying the 
90° RF pulse, the net magnetization vector tips to the transverse plane. When the 90° RF 
pulse is introduced to the protons and immediately after, protons become in-phase; in 
other words, they precess together. Then protons begin to dephase because of protons’ 
spin-spin interactions, magnetic field inhomogeneities, magnetic field susceptibility, and 
chemical shift effects. The dephasing which happens due to the spin-spin effect is called 
T2 relaxation. T2 characterizes the rate of dephasing for protons belonging to a specific 
tissue and can be used as a characteristic of that tissue. To determine the T2 relaxation 
time of a tissue, the amount of transverse magnetization (which is called MR signal) is 
measured using a receiver coil. 
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Figure 2-6 T2 relaxation time demonstration (redrawn from figures 12 and 14, 
reference [68]). (a) 90˚ RF pulse applied to tip the longitudinal magnetization vector 
to transverse plane. (b)Transverse magnetization maximizes instantly after applying 
90º pulse and starts dephasing. (c) T2 relaxation time is defined as the time it takes 
for the transverse magnetization to reduce to 37% of its beginning value. 
The dephasing which is due to all four reasons is called T2
*
. Immediately after tipping the 
net magnetization vector to the transverse plane, the transverse magnetization is at its 
maximum; however, the transverse magnetization begins to dephase and its magnitude 
decreases immediately (Figure 2-6b). T2 relaxation is defined as the time takes the 
transverse magnetization to decay to 37% of its original value (Figure 2-6c). Figure 2-4b 
illustrates a T2-wieghted mouse brain image. White matter has a shorter T2, CSF has a 
longer T2, and gray matter dephases at an intermediate T2 time. These different T2 times 
enable the imaging of tissues with different contrasts. If the MR signal is acquired at 
times when the transverse magnetization curves are widely separated, the generated MRI 
image is called T2-weighted image. By the T2-weighted contrast mechanism, CSF 
contributes to lighter pixels, white matter contributes to darker pixels, and gray matter 
contributes to intermediate gray-scale pixel values. It is good to emphasize that T1 and T2 
relaxations take place simultaneously; therefore, as the transverse magnetization decays, 
the longitudinal magnetization grows. 
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2.4 Pulse sequences 
Generally an MR pulse sequence is the timing of the events such as RF pulses, 
gradient pulses, and signals formed after RF pulses during a typical MRI acquisition. 
First of all, it is necessary to define two important MRI acquisition parameters: TR and 
TE. TE or echo time is the time between the peak of the 90° RF pulse and the peak of the 
echo formed after that RF pulse. TR or repetition time is the time that it takes for a pulse 
sequence to run only one time. Recall that T1 and T2 relaxation phenomena can be 
employed to achieve different contrasts in MRI images. For this purpose, specific 
amounts of TR and TE are selected to change the weighting of T1 and T2 relaxations in 
MRI images. In the following section, the definitions of sequences used in this 
dissertation are described, provided as part of the VnmrJ software accessory (Agilent, 
Santa Clara, CA) [24]. 
2.4.1 GEMS sequence 
The protocol GEMS is a gradient echo 2D multi-slice acquisition technique. The 
gems sequence allows comparatively fast acquisitions and short echo times. Using this 
sequence, acquiring images with imaging time less than 10 seconds per image becomes 
possible. The GEMS sequence allows imaging with short echo time, approximately 3 to 5 
ms, which is necessary in imaging tissues with short T2 time, such as liver. Figure 2-7 
shows the diagram for the GEMS sequence. A single RF pulse (excitation pulse) is used. 
The GEMS sequence also allows a smaller flip angle and shorter TR time. Therefore the 
GEMS sequence is well suited for scout scan, angiography, and contrast agent 
enhancement studies. The GEMS sequence suffers from several limitations, such as 
susceptibility effects, small signal-to-noise-ratio (SNR), and nonsteady-state artifact, 
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which led to the design of a SEMS sequence which will be described later. The 
susceptibility effect is because of the inhomogeneity of the magnetic field. Rapid 
dephasing of spins during TE time in inhomogeneous areas of the magnetic field results 
in signal loss and distortion in these regions (T2* effect). Therefore, by using shorter TE 
time and applying shimming techniques (Shimming is used to reduce the inhomogeneity 
of the magnetic field) the susceptibility effect will be alleviated. Additionally, smaller 
slice thickness and smaller pixels (larger matrix size) help to reduce the susceptibility 
effect. Reduced signal-to-noise-ratio (SNR) because of a smaller flip angle and short TR 
is another limitation of the GEMS sequence. In addition, relatively short TR applied in 
the GEMS sequence leads to a non-steady state, and as a result, the residual transverse 
magnetization can generate echoes due to subsequent RF or gradient pulses. 
 
Figure 2-7 Diagram of the GEMS sequence (redrawn from reference [69], page 91). 
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2.4.2 SEMS sequence 
Figure 2-8 describes the spin echo multi-slice protocol. The sequence employs a 
90˚ excitation RF pulse as well as a 180˚ rewinding RF pulse. The SEMS sequence 
provides high SNR, high resolution, and artifact-free images. The SEMS sequence is 
applied for acquiring T1-weighted and T2-weighted images, to reduce the susceptibility 
effect, and to scan with high SNR where it is needed. The long acquisition time and 
ghosting artifacts are two limitations of the SEMS sequence. In the spin echo imaging to 
acquire a T2-weighted image, TR should be long and in the order of seconds (3 to 4 
seconds) to let the spins completely return to their equilibrium state, resulting in a long 
acquisition time. In addition, in the case of acquiring a T1-weighted image with short TR 
(< 2 second), the ghosting artifact is a probable effect. The ghosting artifact happens 
because of the residual transverse magnetization following the RF pulses and the 
gradients. 
 
Figure 2-8 Diagram of the SEMS sequence (redrawn from reference [69], page 105). 
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2.4.3 SEMSDW sequence 
The SEMSDW sequence is a diffusion-weighted spin echo multiple-slice 
sequence. To acquire a diffusion-weighted image two diffusion-weighting gradients are 
applied, which completely cancel each other out. However, spins which move (due to 
diffusion) along the direction of the applied diffusion gradients will acquire phase 
changes which are not reversed. As a result, intravoxel dephasing occurs and signal is 
lost. The pulse sequence is therefore sensitive to diffusion. Signal decay from diffusion 
can be measured by comparing diffusion sensitive images and normal images. Stejskal-
Tanner gradients are the diffusion-weighting gradients. They might be unipolar, either 
side of the 180 refocussing pulse in a spin echo pulse sequence, as Stejskal and Tanner 
used. In a gradient echo pulse sequence they are bipolar - a positive and then a negative 
gradient. In either case, the two lobes of the gradient will cancel out in tissue where no 
movement occurs. The Stejskal-Tanner equation relates diffusion related measurements 
(S) to measurements without diffusion weighting (S0) as denoted by the equation below:  
       
         (2.2) 
where b is determined by the diffusion-weighting gradient waveform used and ADC is 
the apparent diffusion coefficient. To generate an “apparent diffusion coefficient” map an 
array of diffusion-weighted-imaging (DWI) images with different DW gradients are 
acquired, and using a curve fitting algorithm, local ADC values are calculated. Diffusion 
weighting is obtained by applying two gradients with identical duration delta (δ) and 
amplitude (gdiff), separated by the DELTA (∆). Corresponding b-values are calculated 
according to the Stejskal-Tanner equation 
 
              (  
 
 
) 
(2.3) 
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The diffusion gradients can be applied along each of the readout, phase, and slice 
directions. Acquisition of a spin echo based sequence for diffusion-weighted imaging 
results in high quality, high resolution, and high SNR images. TR for acquiring the 
SEMSDW sequence has to be much larger than the T1 time of a sample (TR in the order 
of several seconds), meaning very long acquisition time in the order of an hour. Motion 
can result in a serious ghosting artifact in diffusion weighted images. During each 
SEMSDW acquisition a single line of k-space is acquired after each excitation; therefore, 
motion between k-space lines which may have phase differences can destroy the MR 
signal significantly. 
2.4.4 MEMS sequence 
MEMS sequence is a multi-echo multi slice sequence which can be used for T1 
and T2 relaxation time measurements in a shorter time comparing with other sequences. 
In a MEMS sequence after a 90º excitation pulse a series of 180º refocusing pulses are 
applied and subsequent excitation pulses are acquired as shown in Figure 2-9. The results 
will be a series of images with the same TRs but different echo times which are multiples 
of the TE. TR time for the MEMS sequence has to be in the order of 3-4 seconds in order 
to avoid ghosting artifact. This makes the acquisition time of a MEMS sequence 
relatively long. 
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Figure 2-9 Diagram of the MEMS sequence (redrawn from reference [69], page 95). 
2.4.5 Magnetization Transfer 
First discovered by Balaban et al., magnetization transfer (MT) is a unique 
contrast mechanism and can be used to provide an alternative contrast method to obtain 
completing morphologic information in addition to common contrasts such as T1 ,T2, and 
proton density [70-72]. MT contrast in MRI images is described as the coupling between 
the macromolecular protons (restricted pool) and the mobile or ‘liquid’ protons (water 
pool). Liquid water protons have a T2 larger than 10 ms but the macromolecules and 
membranes in biological tissues have a too short T2 (i.e. less than 1 ms). Due to the too 
short T2 time, the NMR signal from the protons of bound water is not typically observed 
in MRI. However, using an off-resonance pulse excitation to saturate protons in the 
restricted pool can have a detectable effect on the NMR signal from the mobile (free) 
proton pool. This causes an increase in the T1 of the free water and reduced signal from 
the free water in tissues in which the magnetization transfer mechanism is prevalent. The 
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resultant transverse magnetization is rapidly dephased and the longitudinal magnetization 
requires some time (approximately 5 times T1) to return to equilibrium. This effect 
generates a contrast which depends on the exchange rate between free and bound water. 
This contrast is called magnetization transfer contrast and is a nonspecific indicator of the 
structural integrity of tissues. MT has been applied in magnetic resonance angiography 
(MRA) [73] and description of white matter lesions like multiple sclerosis (MS) disease 
[74] and is under investigation for imaging other tissues [75]. Magnetization transfer ratio 
(MTR) is a quantitative value of the MT influence on tissues. It is the degree of signal 
suppression of a given tissue compared with the common PD or T1-weighted image. The 
MTR can be generated by acquiring two similar images such as PD or T1-wighted, one 
with and one without MT saturation. For a tissue of interest the MTR is calculated from 
the two images following the equation  
     
     
  
 (2.4) 
where Mo and Mt stand for the signal intensity with the saturation pulse off and on 
respectively. MTR has been used in neuroradiology to highlight abnormalities in brain 
structures. Magnetization Transfer Contrast (MTC) is obtained by applying a long RF 
pulse (typically 6-8 ms) with a large RF power (specified as a large flip angle) at an 
offset of several kHz. Figure 2-10 is a comparison between MTC, T1-weighted, and T2-
weighted images of a mouse brain in horizontal sections [71]. 
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Figure 2-10 MRI of a mouse brain in horizontal sections. (a) MTC image. (b) T1 
contrast image. (c) T2 contrast image. Natt et al. showed that MTC enables  
discrimination of densely packed gray matter from white matter in a mouse model 
[71]. 
2.5 Magnetic Resonance Elastography (MRE) 
Magnetic resonance elastography (MRE), first described by Muthupillai et al. in 
1995, is a phase-contrast based MRI technique that uses propagating shear waves through 
tissue to noninvasively characterize mechanical properties of materials such as the shear 
modulus or Young’s modulus. [76]. Historically, physicians have been using palpation to 
discover unusual changes in mechanical properties of tissues, which can be a sign of 
abnormalities such as cancers and tumors. Although diagnosis through palpation is 
constrained to the approachable areas of the body, invasiveness of other conventional 
assessment techniques such as biopsy raised the need for a noninvasive elasticity imaging 
technique which is capable of measuring mechanical properties [76]. In addition, imaging 
techniques such as ultrasound, CT-Scan, and MRI are not able to detect small lesions 
[77]. It was shown that the elasticity variation of different tissues in the body is higher 
compared to the range of changes in physical properties which are the source of contrast 
in conventional imaging modalities [78, 79]. Besides magnetic resonance elastography, 
ultrasound based elastography (UE) introduced by Ophir et al. in 1991, is another 
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noninvasive method for imaging the elasticity of biological tissues. Although UE is a 
successful method and is clinically used, it is limited by the signal to noise ratio (SNR), 
resolution and restricted acoustic window for transmitting ultrasonic waves [76, 80, 81]. 
Over the past two decades MRE has been demonstrated in preliminary human studies as a 
diagnostic method for abnormalities such as tumors, especially in the breast, liver, 
kidney, and prostate, and rehabilitation evaluation, and is currently clinically used for 
assessment of fatty liver diseases. 
The theory of MRE is proved by considering phase shift in the acquired NMR 
signal as a function of dot product of the gradient vector and the position vector [76] 
following the equation 
       ∫           
 
 
   (2.5) 
Let   be the gyromagnetic ratio related to the isochromat rotating inside the magnetic 
field,       be the magnetic field gradient, and      be the spin position vector described 
as  
                (2.6) 
where    represents the beginning position and        is the displacement vector of spin 
around its mean location, and   be the gyromagnetic ratio related to the isochromat 
rotating inside the magnetic field. For a rectangular magnetic field gradient and a nuclear 
spin displacement  
      
              (2.7) 
the phase shift in the acquired NMR signal is simplified to the following equation. 
        
         
 
           (2.8) 
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This equation represents that the accumulated phase shift as a result of the propagating 
mechanical waves with a wave vector of k has a direct relation with dot product of the 
displacement vector (  ) and the gradient vector (  ), the period of the gradient pulse 
(T), and the number of gradient cycles (N). θ is the phase difference between motion 
encoding gradients and the mechanical excitation [76, 82]. 
In practice, an external vibration source is applied to the tissue of interest and the 
resulting displacement within the tissue is calculated based on analysis of phase shift in 
the acquired MR signal. The phase shift image is derived from subtracting two phase-
contrast images acquired by toggling the polarity of motion encoding gradients (MEGs) 
from positive to negative subsequently. This procedure helps to suppress the symmetric 
phase-shift error and improves sensitivity to low amplitude vibrations by a factor of two. 
Depending on the amplitude of the displacement applied to the tissue of interest, an 
appropriate number of MEGs (bipolar rectangular gradients) are chosen to accumulate 
sufficient phase shift depicting the mechanical waves i.e. a higher number of bipolar 
gradients means more sensitivity [83]. 
The shear modulus (shear modulus () correlates transverse strain and resulting 
stress in isotropic materials) can be estimated from the propagating wavelengths through 
the tissue of interest. Considering   (Hz) as the frequency of mechanical vibration and   
(m) as the wavelength of the propagating shear waves,   (m/s), the velocity of shear 
waves, will be depicted by the equation below. 
       (2.9) 
 
.  
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The shear modulus   (Pa) (1Pa=1N/m2) for a simple isotropic linear-elastic 
material is calculated as the product of its mass density (kg/m
3
) and squared velocity as 
described by the following equation. 
       (2.10) 
Measuring the shear modulus depends on applied vibration frequency; therefore, 
the calculated shear modulus for a material in a specific frequency is called shear 
stiffness which is also denoted by  . The real and imaginary parts of the complex shear 
modulus are referred to as storage modulus and loss modulus respectively. The storage 
modulus represents elastic properties of a material while the loss modulus describes how 
viscous it is [84]. Furthermore, to calculate the local stiffness values from the 
displacement distribution, different algorithms such as solving an inverse problem have 
been developed [85-87]. 
A typical gradient-echo based MRE pulse sequence is shown in Figure 2-11 including the 
radio frequency pulse, slice-selection gradient, phase-encoding gradient, and frequency-
encoding (or readout) gradient. The MEGs are shown in the frequency-encoding direction 
only; however, motion occurring in any direction can be encoded into the phase of the 
MR image by manipulating the axes on which the MEGs are placed. Two wave images 
are typically collected with a positive and a negative MEG, and a phase-difference image 
is calculated, either by subtraction or complex division, to remove all phase information 
not related to the imparted motion. Besides, multiple phase offsets θ, evenly distributed 
over a period of the mechanical excitations, are selected in order to acquire time-
dependent data and show the propagation of the wave through the tissue of interest. The 
motion-encoding capability of this technique is very sensitive and can detect motion on 
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the order of 100’s of nanometers [88]. The motion encoding gradients can be 
implemented with many MR imaging sequences; as such we developed gradient-echo, 
spin-echo, and multiple-echo spin-echo based MRE sequences and installed them on 
VnmrJ 3.1 software (Agilent, Santa Clara, California).  
 
Figure 2-11 Diagram of the gradient-echo MRE pulse sequence (redrawn from 
references [69] and [8]). A negative motion encoding gradient (MEG) used for 
phase-contrast imaging is shown. θ is the delay between the motion waveform and 
the MEG. 
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CHAPTER 3 
 
BIOREACTORS FOR TISSUE ENGINEERING: PRINCIPLES, DESIGN AND OPERATION 
 
3.1 Tissue Engineering/ Regenerative Medicine 
Tissue engineering is a rapidly growing interdisciplinary field in medicine 
combining engineering and life science to develop replacements for damaged tissues [24, 
89]. The increasing need for implantation of tissues and organs is a critical situation and a 
crisis for regenerative and reconstructive medicine [90, 91]. Tissue engineering employs 
cells, biomaterials, and biologically active molecules in order to construct functional 
tissues. Artificial tissues such as skin, fat, bone, and cartilage have been regenerated 
using tissue engineering techniques; however, they are not widely used for curing human 
patients yet. The terms tissue engineering and regenerative medicine are identical in most 
cases. The regenerative medicine term embodies a wider field including the research on 
the capability of the body to reconstruct its tissues by aid of applied biomaterials. Besides 
medical applications, the regenerative medicine extends to non-therapeutic applications 
such as the development of engineered tissues to work as biological or chemical sensors. 
Tissue loss in the body is a widespread problem and it is challenging and costly to repair. 
Many diseases or disorders can result in tissue loss which might lead to disability. For 
example, trauma, infection, neoplasm, metabolic disorders, genetic and congenetic 
conditions can be causes of tissue losses [92-94]. One of the frequent disorders is 
orthopedic problems which sometimes cannot heal without interventional treatments. For 
instance bone tissue diseases including critical-size bone defect [95], bone tumors [96], 
and spinal fusion surgery [97] are a major problem for healthcare systems. However, 
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treatment options for each of these diseases have some limitations and can be improved 
by tissue engineering techniques generating bone tissue from cells using a structural 
scaffold in vitro to implant in the defect sites [95]. 
Cells, biomaterials, and biomolecules play an important role in the process of 
forming engineered tissues. Figure 3-1 demonstrates the structure of an intestine wall 
tissue. Cells are the building blocks of tissues in the body and are held together by cell-
cell adhesions, extracellular matrices, or both [98]. The extracellular matrix secreted by 
cells, is the assembly of extracellular molecules that deliver structural and biochemical 
support to the cells around it. Besides cells, biomaterials are employed in tissue 
engineering to physically or chemically enhance the organization, growth, and 
differentiation of cells. Biomolecules in the form of growth factors, differentiation 
factors, or as any kind of proteins are incorporated in the culture. 
 
Figure 3-1 Basic illustration of a cross-section through part of the intestine wall 
showing the assembly of cells stuck together by cell-cell adhesions, extracellular 
matrices, or both [99]. 
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Stem cells are the most common form of cells used in tissue engineering; 
however, partially differentiated cells are also applied. Cells from different origins have 
been used in tissue engineering which can be from the patient’s body (autologous), from 
another person (allogeneic), or from animals (xenogeneic). Obviously, tissue engineering 
products do not come without risk, and given the difficulty and cost of the tissue 
engineering based therapies, other approaches are also being chased. While scientists 
have worked to overcome many of the challenges regarding tissue engineering, ethical 
and scientific concerns such as long-term chromosomal stability, tumor formation, and 
ethical standards for harvesting of ova still continue to be addressed. 
3.2 Stem Cells 
There is confusion in the terminology of stem cells due to the continuous 
evolution of this area. Stem cells conventionally are classified as totipotent, pluripotent, 
or multipotent because of their ability to differentiate into various tissues. Totipotent stem 
cells are defined to have the ability to give rise to all likely cell types of an organ. 
Pluripotent stem cells were known to have less capability for differentiation than 
totipotent stem cells and cannot produce extraembryonic tissues or form an entire 
organism. However, recent studies showed that pluripotent cells can actually give rise to 
some of the extraembryonic tissues [100]. Multipotent stem cells were thought to have a 
more restricted differentiation capability compared with pluripotent cells and can only 
give rise to a few lineages that build a limited number of tissues. For instance, adult stem 
cells found in adult tissues, as an example of multipotent stem cells, were thought to be 
only capable of differentiating into cells of that specific tissue type. However, it has now 
been reported that the adult stem cells can differentiate into cells of other lineages not 
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from the same origin [101]. Mesenchymal stem cells (MSCs), another type of multipotent 
stem cells, have been demonstrated to differentiate into a variety of non-mesodermal 
tissue types such as ectodermal astrocytes [102], endodermal hepatocytes [103], 
osteoblasts (bone cells) [104], chondrocytes (cartilage cells) [105], and adipocytes (fat 
cells) [106]. Stem cells are also categorized based on their capability to produce a single 
lineage or multiple lineages within a tissue which are called unipotent and oligopotent 
respectively. Figure 3-2 summarizes the types of human stem cells including embryonic 
stem cells, fetal stem cells, umbilicus stem cells, and adult stem cells. 
 
Figure 3-2 Various types of human stem cells categorized by their origins (Bongso 
and Lee [23]). The bold rout is for MSCs. 
3.3 Mesenchymal Stem Cells 
Mesenchymal Stem Cells (MSCs) are a type of multipotant cells which are found 
in the mesodermal (middle) cells layer in the trilaminar embryo. MSCs develop into a 
connective tissue called mesenchyme which persists after birth. The history of MSCs 
goes back to a series of studies in the 1960s and 1970s by Friedenstein and his colleagues 
[107-110]. They showed that a minor subpopulation of bone marrow (BM) cells had the 
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potential for osteogenesis and their origin was from the stromal compartment of BM. 
They could distinguish these cells from the majority of hematopoietic cells due to their 
fast adherence capability to tissue culture chambers [108]. The currently popular term of 
mesenchymal stem cells was first used by Caplan in 1991 [111]. He described that the 
generation of bone and cartilage tissues in embryos and adults involves the growth of a 
small number of cells called MSCs. He suggested that MSCs provide the foundation for 
self-cell repair and engineering tissues to be used in therapy. A privilege of MSCs is that 
they do not evoke the same level of ethical issues as those linked to the human embryonic 
stem cells [112]. Besides ethical issues, a feeder layer with a mouse origin is necessary 
for isolation and expansion of the human embryonic stem cells. The presence of these 
animal cells in the production process of embryonic stem cells is a large concern for 
regulatory authorities [113]. Another privilege is that MSCs can be taken from a patient, 
be used for engineering required tissue, and then be implanted back into the same patient 
without evoking any immune response in the body. Researchers have looked into the 
influences of hormones, vitamins, growth factors and cytokines in growth and 
differentiation of MSCs [114]. Using MSCs in the tissue engineering field can address a 
wide range of clinical applications [115, 116].  
MSCs were first detached from mammalian bone marrow then they have were 
found in different tissues such as periosteum, trabecular bone, adipose tissue, synovium, 
skeletal muscle, deciduous teeth [117], brain, spleen, liver, kidney, lung, thymus, 
pancreas [115], dermis [118], blood [119, 120], tendon and ligament. Dazzi et al. 
reported that MSCs have been found in different species including humans, mice, rats, 
baboons, sheep, dogs, pigs, cows, and horses [121]. 
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MSCs are often called bone marrow stromal cells because they are commonly 
collected from the stromal section of bone marrow. It is known that mammalian bone 
marrow consists of hematopoietic, endothelial and stromal cellular systems [122, 123]. 
Different molecular signals have been applied to stimulate differentiation of MSCs 
toward a specific lineage. These signals include growth factors and cytokines such as 
fibroblast growth factor (FGF), transforming growth factor-beta (TGF-β1), bone 
morphogenetic protein (BMP), hormones such as dexamethasone, vitamins such as 
ascorbic acid, and chemicals such as β-glycerophosphate [124, 125]. 
Bone tissue engineering is one of the most prevalent applications of MSCs. 
Bruder et al. was the first team, in a proof-of-concept study, to report bone repair in large 
animals using MSCs. They investigated the effect of cultured autologous mesenchymal 
stem cells on the healing of critical-sized segmental defects in the femora of adult female 
dogs for 16 weeks [126, 127]. Bone tissue repair using MSCs is now largely accepted and 
a wide spectrum of research can be found in literature [128-130]. Another major 
application of MSCs in tissue engineering is cartilage repair. Repair of adult cartilage 
tissue has some difficulties because of the avascular nature of cartilage and the limited 
potential of chondrocytes to proliferate [131]. MSCs seeded within a 3D scaffold and 
treated with members of growth factors, including the transforming growth factor-β 
(TGF-β), have the capability of developing into chondrocytes [132]. Figure 3-3 
demonstrates the growth factors and mechanical stimulations, commonly applied on 
MSCs to grow and differentiate toward cartilage and bone [133]. 
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Figure 3-3 Effect of growth factors and mechanical stimulations on MSCs 
differentiation into chondrogenic and osteogenic lineages. High oxygen 
concentration and shear stress have negative effects on MSCs renewal. Cyclic strain 
and shear stress have positive effects on differentiation into chondrogenic and 
osteogenic lineages respectively (redrawn from reference [133]).  
3.4 Bioreactors 
Bioreactors have been used in the production processes of the food, 
biopharmaceutical, biochemical and tissue engineering industries over many years. A 
bioreactor can be any device or system designed to provide a biologically active 
environment. In our case, a bioreactor particularly refers to a device or system 
manufactured to culture cells or tissues in an environment that mimics in vivo conditions 
(e.g., nutrients, growth factors, and mechanical environment). These systems are being 
improved with applications in tissue engineering and biochemical engineering. A 
classification of various bioreactors based on their geometries is shown in Figure 3-4. 
Petri dishes, flasks, and plastic bags are the simplest bioreactors, which include a static 
chamber without any stirring component. Cells are placed inside cell culture media 
consisting of components within serum that provides the required microenvironment and 
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are accountable for growth and differentiation of MSCs. To regulate the media, gas 
exchange, including oxygen and carbon dioxide, happens at the media/gas boundary. In 
the following sections we will review various types of the bioreactors available in the 
literature. 
 
Figure 3-4 Classification of bioreactors based on their geometries 
3.4.1 Mixed Bioreactors 
3.4.1.1 Spinner flasks 
The spinner-flask bioreactor consists of a cylindrical glass or plastic container and 
a central stirring element, usually a magnetic stirrer shaft, and side arms. The stirring 
element ensures the culture media are fairly mixed. Cultured tissues are suspended into 
the media [134, 135]. Figure 3-5a shows the prototype of a spinner-flask bioreactor [134]. 
The rotation of stirring bar at the bottom of the flask is for promoting the mass transfer of 
the nutrients. Side arms are used for the addition and removal of cells and media, and 
gassing with 5% CO2 concentration air. The prototype of the spinner-flask was provided 
by Freed and Vunjak-Novakovic of MIT and used to grow cartilage. The cylindrical glass 
flask includes four symmetrically placed pins to hold constructs. The constructs are 
separated by spacers made of silicone tubing (Figure 3-5b). Mixing is done by a magnetic 
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stirrer at the bottom of the flask. In several studies spinner flasks were used for 
cultivation of MSCs with osteogenic differentiation [136-139]. 
  
(a) (b) 
Figure 3-5 Prototype and model spinner-flask bioreactors [134]. (a) Prototype 
bioreactor. The rotating stir bar at the bottom is used for mixing the media. (b) 
Prototype construct array. Four needles are used to hold the constructs which are 
attached to the cap of the flask. 
3.4.1.2 Rotating-wall bioreactors 
The rotating-wall bioreactor was first developed by Wolf (NASA Johnson Space 
Center) and Schwarz (NASA contractor Krug Life Sciences) [140, 141] to study the 
effects of microgravity on human cells on a space shuttle [142]. A rotating-wall 
bioreactor includes a horizontally rotating cylinder filled with culture media as shown in 
Figure 3-6a. There is no gas-liquid interface and liquid rotates inside the cylinder at the 
same rotating rate as the wall. The rotation speed of the media is considered identical and 
opposite of the sedimentation rate of cells or micro-carriers so that the cell suspension 
can stay in a state of ‘free-fall’ (Figure 3-6b). Viscous flow around the falling particles 
reduces the thickness of the boundary layer surrounding the cells inside the particles, 
resulting in a shorter diffusion distance from the bulk media to the cells. Oxygenation of 
the media is provided by a silicone membrane wrapped around a central cylinder. Figure 
3-7 shows an advanced rotating-wall bioreactor manufactured by Synthecon Inc. 
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(a) (b) 
Figure 3-6 (a) A ground-test model of the NASA Bioreactor shows the key elements, 
a rotating plastic cylinder enclosing a tubular membrane that infuses growth media 
and oxygen and removes wastes. (b) Cell constructs grown in a rotating bioreactor 
on Earth (left) eventually become too large to stay suspended in the nutrient media. 
In the microgravity of orbit, the cells stay suspended. Rotation then is needed for 
gentle stirring to replenish the media around the cells [143]. 
 
Figure 3-7 Synthecon Inc. has further advanced the bioreactor technology, creating 
platforms like this perfused culture system that allows the cell growth medium to be 
exchanged, sampled, or modified without stopping the bioreactor’s rotation and 
potentially damaging the cells [143]. 
3.4.1.3 Wave bioreactors 
A wave bioreactor system developed by Singh et al. is shown in Figure 3-8. This 
bioreactor provides a controlled wave motion for mixing the culture. It delivers higher 
oxygen transfer compared with spinner flasks and has been demonstrated as an 
alternative for stirred-tank bioreactors for working volumes between 1 and 100 L [144]. 
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Their setup includes gas-permeable bags simply placed on a rocker. By swing of the 
rocker, a wave motion is generated within the gas-permeable bags. Using commercially 
available polyethylene bags can be a problem for this bioreactor system due to their 
cholesterol adsorption. The problem could be solved by pre-treating the bags or switching 
them with inert fluorinated ethylene propylene [145]. The disposable contained bag 
system has been effectively used in clinical applications; however, it can be used for 
MSCs growth and differentiation as well. 
 
Figure 3-8 Disposable wave bioreactor for cell culture designed by Singh in 1998 
[144]. 
3.4.2 Perfusion Bioreactors 
3.4.2.1 Column bioreactors 
Column bioreactors are designed such that the culture media can flow uniformly 
through the column govern by hydrodynamic principles [146]. Figure 3-9 represents the 
column bioreactor developed by Veliky et al. in 1981 [147, 148]. The hydraulic 
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resistance of the column bed and the form of the headers attached to the columns are two 
important factors forming the flow distribution. Apparently, non-uniform hydraulic 
permeability of the cultured scaffold results in non-uniform flow distribution. In other 
words, if the scaffold porosity is uniform, the flow of media will be uniform and will 
mainly depend on the hydraulic permeability of the scaffold. Figure 3-9b shows the 
column bioreactor designed by Bancroft et al. [149, 150]. The scaffold is placed in a 
tubular cassette held between two ‘O’ rings used for sealing purpose. This causes the 
media to flow through the scaffold rather than around it. Studies show that media flow 
stimulates oxygen transport [151], osteogenesis, and mineralization [149, 152-155]. 
Goldstein et al. and Wendt et al. in two different studies reported that osteogenic 
differentiation is improved in perfusion bioreactors compared with spinner flask and 
rotating-wall bioreactors [156, 157]. A challenge to the static and perfusion systems is 
uniform seeding of the scaffold.  Applications of oscillatory flow [157] or low pressure 
[158] were investigated to overcome this problem. The perfusion bioreactors have also 
been applied for cartilage tissue engineering [159-163]. Mahmoudifar, et al. used a 
column bioreactor to culture chondrocytes isolated from human fetal epiphyseal cartilage 
and seeded into polyglycolic acid (PGA) scaffolds to regenerate tissue-engineered 
cartilage [164]. The bioreactor is composed of a 15-mm glass tube including three 
separate parts assembled together with uses of a double-flanged section in the middle and 
two single-flanged sections on either side. The scaffold is placed in the glass tube within 
the double-flanged section after seeding and glued using to the glass walls using Selleys 
Kwik Grip contact adhesive (Selleys, Padstow, Australia). After assembling three 
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bioreactors via joint clips, they are connected using silicone tubing to a medium reservoir 
(500 ml Schott bottle). 
 
 
 
 
 
(a) (b) 
Figure 3-9 (a) Column bioreactor designed by Veliky et al. in 1981 [148]: 1) Column 
with immobilized cells in Ca-alginate beads; 2) Air inlet; 3) Air outlet; 4) Airlift 
pump; 5) Medium buffer reservoir; 6) Sampling outlet. (b) Column bioreactor 
designed by Bancroft et al. [149]. Top: Flow chamber and cassette diagram; Bottom: 
Flow perfusion system flow circuit diagram. 
3.4.2.2 Parallel-plates 
A parallel-plates bioreactor designed by Peng et al. is a radial-flow-type 
bioreactor used for the growth and differentiation of parenchymal cells ex vivo [165]. The 
bioreactor is composed of two main sections including a gas section and liquid-filled 
bottom section. The gas section is separated from the bottom section by a membrane 
which is gas-permeable but liquid-impermeable. The liquid-filled bottom section consists 
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of a tissue culture plastic surface for support of anchorage-dependent cells (Figure 3-10).  
Culture media flow radially within the liquid section over cells and exit into a waste 
reservoir. The bioreactor has been placed into a cell production system to inoculate and 
harvest the cell culture. This cell production system is composed of an incubator and a 
processor. The bioreactor, a disposable cell cassette, was designed to fit into the 
processor and incubator units. Dennis et al. employed the parallel-plates perfusion 
bioreactor to significantly give rise to CFU-F and progenitors with osteogenic potential 
from bone marrow mononuclear cells [166]. 
 
 
 
 
(a) (b) 
Figure 3-10 (a) Schematic representation of the microchannel parallel plate 
bioreactors designed by Roy et al. [167]. The reactor has a semipermeable 
membrane on the upper surface for internal oxygenation. (b) Right bottom is the 
bioreactor flow schematic designed by Gemmiti et al. [168]. The bioreactor is 
comprised of two media chambers, one above and one below the tissue, which 
resides on a semi-permeable membrane. The upper media chamber is a rectangular. 
Flow of nutrient media through the upper chamber results in a parabolic velocity 
profile when fully developed. Consequently, a shear stress is developed in the 
chamber that is maximal at the surface of the tissue. Left is the bioreactor assembly. 
Right top is the flow circuit of the bioreactor. 
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3.4.2.3 Hollow- fiber bioreactor 
The clinical use of hollow-fiber devices for cell culture was introduced in 1990 by 
Knazek et al. [169]. During these years, hollow-fiber bioreactors have been used for 
mammalian cell culture experiments including lymphocyte expansion, gene transfer to 
hematopoietic cells, generation of recombinant proteins and viruses, and hepatocyte 
culture [170]. Hollow-fiber bioreactors have been applied for cartilage tissue engineering. 
Fourier-transform infrared imaging spectroscopy was used to measure the distribution of 
collagen, proteoglycan and glycosaminoglycan content within the hollow-fiber bioreactor  
[171]. Hollow-fiber bioreactors are widely used for renal dialysis, where blood is passed 
through the intracapillary side of a hollow-fiber membrane dialyzer with a low molecular 
weight cut-off [172]. Hollow-fiber membranes are used in hemodialysis as artificial 
kidneys to cure renal disease. 
 
Figure 3-11 Hollow fiber bioreactor [173]. a) Circuit. b) Longitudinal and cross-
sectional views. 
A hollow-fiber bioreactor is composed of intracapillary and extracapillary spaces. 
A bundle of hollow-fibers is potted in resin and intracapillary flow is allocated to the 
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hollow-fiber bundle by especially-designed headers (Figure 3-11). Hollow-fiber 
bioreactors can be designed so that flow allocates equally to each hollow fiber in the 
bundle [146]. 
 The cells attached to the inside surface of hollow fibers are exposed to a uniform 
shear stress because of the parabolic velocity profile of the flow inside the hollow fibers. 
This shear stress is directly proportional to the intracapillary flow rate. All hollow fibers 
are secured in a cylindrical chamber with inlets and outlets for flow of media around 
hollow fibers. Because of the semi-permeable structure of the hollow-fiber membrane, 
molecular species can permeate based on the pore size of it. High upstream pressure in 
hollow-fiber bundles can push intracapillary medium out of the upstream side of the 
fibers, which is then pulled into the fiber downstream. Termed Starling flow, this 
secondary flow has a tendency to push cells towards the downstream end of the hollow 
fibers  [174]. This flow does not intervene in the function of hollow fiber dialysis devices 
because of their much lower hydraulic permeability compared with macroporous 
membranes [141]. 
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CHAPTER 4 
 
THE e-INCUBATOR: AN MRI-COMPATIBLE AUTONOMOUS INCUBATION SYSTEM 
 
This chapter is based on previously published work by the author [175]. Shadi F. 
Othman, Karin Wartella, Vahid Khalilzad-Sharghi, and Huihui Xu. Tissue Engineering 
Part C: Methods. doi:10.1089/ten.TEC.2014.0273. Copyright©2014 Mary Ann Liebert, 
Inc. publishers. 
4.1 Introduction 
The development of instruments that enable noninvasive ex vivo testing and in 
vitro imaging during tissue culture procedures holds great promise in modern medicine 
[176, 177]. For example, such instruments can potentially help identify and screen novel 
therapeutics in different disease models used by drug companies and academic 
researchers. With the application of imaging to disease models more complete and 
informative datasets can be obtained. Imaging can replace terminal sacrifice based 
assays, through ex vivo noninvasive, longitudinal imaging. Specifically, these instruments 
could visualize the activity of incubated brain slices, such as MR relaxometry, diffusion, 
molecular content through magnetization transfer or MR spectroscopy, and stiffness 
measurement using MR Elastography [178]. Also, it is possible to use diffusion-weighted 
MRI [176] to study the acute temporal evolution of diffusion changes in multiple brain 
slices following experimental perturbation. Another example of an expected benefit from 
such instruments is in the field of tissue engineering. The concept of tissue engineering 
was introduced over 25 years ago, but a limited number of products have been approved 
for clinical application [179]. The tissue engineering community has been vocal in 
seeking noninvasive instruments to assess and steer the development of tissue-engineered 
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constructs [180]. Thus, offering an instrument that can facilitate noninvasive visualization 
capabilities using traditional medical imaging technologies is expected to expedite the 
translation of tissue-engineered products to clinical settings.  
Medical imaging technologies have proved their superiority in clinical settings for 
the diagnosis of various diseases. These imaging technologies have the potential to play a 
major role in tissue culture applications. Among such imaging technologies, magnetic 
resonance imaging (MRI) is highly desirable because it does not use ionizing radiation 
and is therefore well suited for longitudinal studies. However, one major problem is that a 
specimen allocated to a test tube for imaging cannot be tested for a prolonged period of 
time nor can it be returned to the incubator. In turn, the sample is wasted due to potential 
contamination and transfer in a sub-optimal growth environment. Until this problem is 
resolved, the benefits that medical imaging can provide to these diverse fields cannot be 
fully realized. In this paper, we present a miniature MRI-compatible incubator, termed 
the e-incubator. The e-incubator is an initial step in developing the next generation of 
instruments that can enable real-time, on-board imaging for tissue specimen testing and 
clinical applications. The e-incubator is a standalone unit that is controlled via a 
microcontroller (MCU). The MCU acts as a central control unit to automatically sense 
and regulate physiological conditions (e.g., temperature, CO2, and pH) and to perform 
media exchange for cultured constructs. In the current design of the e-incubator, MRI 
compatibility is pursued because MRI represents the most-sophisticated, clinically viable 
technique available today. With proper adjustments, the design of the e-incubator can be 
revised to incorporate other imaging modalities such as computed tomography (CT) and 
optical imaging.  
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Since late 1990s, perfusion-based tissue culture systems, such as hollow fiber 
bioreactors (HFBRs), have been designed in parallel with improvements in high-
resolution MRI. While HFBRs are compatible with MRI, most of the available designs 
fail to address how to maintain an optimal growth environment for tissues. Additionally, 
most HFBRs can only function in a continuous perfusion mode, which requires a pause in 
flow during imaging sessions. In turn, the quality of the MR images is compromised by 
magnetic susceptibility artifacts due to hollow fibers [181-183]. Still, these studies 
highlight the continuous pursuit of technological innovation to dynamically monitor the 
development of tissue-engineered constructs. Importantly, the invention of the e-
incubator provides a standalone unit that eliminates the need to use unwieldy incubator 
units. Our concurrent tissue culture and evaluation approach offers an innovative scheme 
to study, in real time, the underlying mechanisms associated with the structural and 
functional evolution of tissues while they are growing.  
Given its clinical significance, we selected tissue-engineered bone as a model 
system to demonstrate the feasibility of our instrument. Trauma, osteoporosis, and bone 
cancer together cause over two million cases of bone injury or loss in the United States 
annually [184]. Natural bone healing following injury or disease is the preferred option to 
overcome osteogenic tissue loss and bone damage. However, because bone has a limited 
capability to regenerate and remodel, often the surgeon will need to implant synthetic 
materials or bone grafts at the site of injury. Specifically, for fractures that do not heal 
naturally, approximately one million cases of bone grafts are performed annually in the 
United States as treatment, resulting in an estimated annual cost of over $3 billion. Both 
autologous and allogeneic bone grafts are used clinically as bone substitutes. However, 
48 
 
  
 
 
the availability of compatible grafts is limited given that harvesting bone is painful, and 
the procedure carries significant risk of infection. Therefore, tissue-engineered bone has 
emerged as a promising alternative for creating functional substitutes [185]. Still, one 
challenge in the clinical utility of tissue-engineered bone is the avoidance of non-specific 
tissue development (i.e., ensuring stable expression of the osteogenic phenotype prior to 
implantation). In particular, the clinically relevant event that murine mesenchymal stem 
cells (MSCs) can transform into a malignant disease during in vivo regeneration has been 
documented [186, 187]. 
Successful tissue engineering requires gradual assessment of developing tissues. 
The different growth stages of tissue-engineered bone constructs are defined by changes 
in the osteogenic phenotype (i.e., cell proliferation followed by extracellular matrix 
[ECM] development and finally bone mineralization). Specific gene expression at each 
stage characterizes this progression [188]. Conventional biochemical and 
immunohistochemical analyses provide critical markers of osteogenic development, 
including alkaline phosphatase (ALP), collagen type 1 (COLL1), osteopontin (OPN), 
osteocalcin (OCN), and bone sialoprotein (BSP) [189-191]. For example, OCN is a bone 
turnover marker and appears concurrently with ECM mineralization [38, 192]. 
Nevertheless, such immunohistochemical analyses are destructive to the tissue.  
Currently, no reliable technique has been established that can measure osteogenic 
phenotype expression for tissue-engineered constructs in a continuous and noninvasive 
manner, similar to the proposed technique in this study. Only recently have researchers 
begun to explore the potential for medical imaging techniques to monitor developing 
bone tissues. In particular, MRI can visualize structural and functional changes associated 
49 
 
  
 
 
with bone formation [1, 177, 182, 183, 193]. For example, MRI relaxometry parameters, 
such as T2-relaxation time, can be correlated with ALP activity. Similarly, evaluation of 
the magnetization transfer (MT) effect can reveal changes, with high specificity, in 
collagen content associated with osteogenesis.  
4.2 Experimental 
4.2.1 Specimen preparation 
Osteogenic tissue-engineered constructs were prepared using human 
mesenchymal stem cells (hMSCs), isolated from donated, commercially available, fresh 
adult human bone marrow (Lonza, Walkersville, MD) seeded into a biodegradable, 
sterile, gelatin scaffold (Gelfoam®, Baxter Healthcare Corporation, Hayward, CA); this 
scaffold was trimmed into 3.5 mm x 3.5 mm x 4 mm sections at a density of 10
6 
cells/mL. 
Second, similar constructs were prepared using aqueous silk sponges [194] with 
dimensions of 8 mm x 3 mm at a density of 10 x10
6 
cells/mL. For both constructs, sterile 
scaffolds were placed in 24-well plate, seeded with hMSCs and placed in the incubator. 
Following 2 hours, additional growth medium was added to the wells. After 24 hours, the 
medium was replaced with osteogenic medium containing DMEM, 10% FBS, 0.5% 
antibiotic/antimycotic, 100 nM dexamethasone, 10 mM, β-glycerophosphate, and 0.05 
mM ascorbic acid 2-phosphate (Sigma, St. Louis, MO).). 48 hours post-seeding, one 
osteogenic construct was placed in the e-incubator, while the other was maintained in a 
standard incubator. For studying both constructs simultaneously inside the e-incubator, 
the silk scaffold was punched into a 5 mm diameter. 
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4.2.2 e-Incubator design 
The MRI-compatible e-incubator (patent pending; application number: 
13/953,984) [195] provides an enclosed but autonomously controlled and user-
configurable environment for tissue culture and development in vitro (Figure 4). A key 
feature of the e-incubator is its ability to operate in a stand-alone manner through the use 
of an MCU. By integrating both hardware and software, MCUs are embedded as brains in 
almost all smart devices, from consumer electronics to automobiles to medical systems. 
Because of its versatility and relative cost effectiveness, the Microchip PIC® MCU 
(Microchip Technology Inc., Chandler, AZ) was used to control the e-incubator, thus 
eliminating the need for complimentary hardware and software. The e-incubator design is 
built upon the most general incubation environmental parameters, including temperature, 
CO2, pH, and nutrient/waste exchange. The incubation system was fabricated from a 
polycarbonate, autoclavable, tissue imaging (TI) culture chamber constructed on top of a 
support chamber; the support chamber was attached to a specially designed holder 
inserted into the imaging volume of the magnet. When implementing the design, the 
challenge of MRI compatibility was specifically addressed. For instance, the design 
required that the internal environment inside of the TI chamber, as shown Figure 4-1, can 
be detected and adjusted with minimal MR magnetic susceptibility artifacts. The solution 
was to use an MRI-compatible, fiber optic temperature probe (Small Animal Instruments, 
Inc., Stony Brook, NY) adjacent to the construct inside the inner TI chamber. An air 
blowing heating system (SA Instrument, Inc, Stony Brook, NY) along with a silicone 
rubber heater (O.E.M. Heaters, Saint Paul, MN) together maintained the temperature of 
the culture media. A silicon rubber heater was mounted inside a heating chamber; to 
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direct warm air toward the culture chamber, a flexible air duct connected to the blowing 
heater was inserted from the top of the magnet’s bore. Both heaters toggled on and off 
based on the temperature reported by a probe inside the media, which resulted in 
maintaining the desired temperature. A gas mixing system utilized two mass flow 
controllers (MFCs) (Cole-Parmer, Vernon Hills, IL) to produce a mixture containing 95% 
air and 5% CO2.  
 
Figure 4-1 Schematic of the e-incubator system where the microcontroller unit 
(MCU) is the brain controlling e-incubator culture environment. The MCU initiates 
the peristaltic pump to flow a predetermined level of fresh medium to the tissue 
imaging chamber while the culture environment is maintained for temperature, 
CO2, and pH. The system functions as follows: (i) a feedback system maintains the 
CO2 level by activating two flow meters for mixing CO2 and air based on the value 
recorded by the CO2 sensor positioned on the output flow from the TI chamber; (ii) 
the temperature, measured by (iii), adjusts the quality of the medium through 
scheduled exchange three times a day, during which time a sensor measures the pH 
value. 
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The CO2 concentration is continuously monitored using a Co2 sensor (CO2Meter, 
Ormond Beach, FL). The media pH is measured through a pH sensor (Atlas Scientific, 
Brooklyn, NY) mounted in the middle of the media line from the culture chamber to the 
media reservoir. The recorded pH was used to calibrate the media exchange intervals. A 
peristaltic pump (Thermofisher Scientific, Barrington, IL) with adjustable flow rate was 
used to circulate the media between the culture chamber and the media reservoir that is 
kept at 37
 o
C and refilled weekly. 
The e-incubator system incorporated signal processing of all sensors, pump and 
heater driving, communication with user interface, and the data logging application using 
a PIC16f1917 MCU (Microchip Technology Inc., Chandler, AZ). This is an 8 bit model 
that includes 8 channels in built 10-bit resolution analog-to-digital converter (ADC). The 
MCU software communicated between all sensors and other electrical and mechanical 
elements via a pre-programmed C program to ensure environmental conditions (i.e., 
temperature, CO2, and pH) were properly maintained for optimal growth of the tissue-
engineered construct. When turning on the system for the first time, an initialization is 
used in order to pump the media out from the culture chamber and replace it with fresh 
media. The system includes and overheating protection circuit to shut down the heaters in 
case of temperature probe failure. All data including temperature, pH value, CO2 control 
system status, date, and time were shown on a liquid-crystal display (LCD) and 
transferred to a personal computer (PC) using a serial port. Finally, a surveillance camera 
was used for observation over the internet using a smartphone. 
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4.2.3 e-Incubator Setup and loading  
The e-incubator was composed of an upper tissue imaging (TI) chamber and 
lower heating chamber, machined from stock polycarbonate. Initially, adapted Transwell-
Clear Permeable (Corning Inc., Corning, NY) plate inserts were modified and positioned 
within the TI chamber for containment of the tissue construct. A nylon washer and 
meshing was situated on top of the insert to keep the construct from floating out of the 
insert. To avoid bubbles that interfere with imaging, a new tissue holder was designed 
and manufactured from polysulphone. 
Prior to setup of the e-incubator all tubes and connections were placed in 
sterilization pouches for a steam autoclave, including the tissue holder. In a biosafety 
cabinet, the TI chamber and pH probe were sterilized with 1M NaOH for 1 hour, 
followed by a 3 rinses with sterile dH2O, and loaded basic medium until setup. A sterile 
250 ml Fisherbrand bottle was filled with 100 ml of osteogenic medium (as above) and 
connected with the 3 hole lid. The 3 hole lid connected to medium tubing that connected 
to the pH meter flow-through cell. The opposite end of the flow through cell connected to 
additional tubing that was threaded through the e-incubator holder and connected to the 
bottom of the heating chamber. The tubing for the gas lines were also threaded through 
the holder, an affixed to the TI chamber lid after the construct was loaded. An osteogenic 
construct was placed in the tissue holder inside the TI chamber and a 3-D printed lid was 
placed on top to keep it within the holder. All parts were removed from the biosafety 
cabinet, the medium tube placed in the peristaltic pump, gas tubes connected, and the pH 
meter, heater, and temperature probe wires connected to the MCU. The MCU was turned 
on and the program initiated. The chamber was attached to the e-incubator holder with 
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nylon set screws and placed within the magnet. Initial imaging was performed to evaluate 
placement of the chamber and tissue in the magnet.  
4.2.4 Device Verification  
The e-incubator samples were tested daily for four weeks with MRI by measuring 
different MR parameters. Following e-incubator culture, the samples were removed from 
the traditional incubator and the e-incubator, cut into two halves and tested by live-dead 
assay and conventional histology. Different constructs cultured in the e-incubator were 
compared by measuring different MR parameters followed by histology as detailed 
below. 
4.2.5 Magnetic Resonance Imaging 
The tissue-engineered bone construct was loaded into the e-incubator tissue 
holder, and then the 3 cm cylindrical chamber system was inserted into a 4 cm Millipede 
radiofrequency (RF) imaging probe of a 9.4 T (400 MHz for protons) 89 mm vertical 
bore MRI scanner (Agilent, Santa Clara, CA), equipped with 100 G/cm maximum triple 
axis gradients. The construct was positioned in the center of the magnet to ensure the best 
magnetic field and MR signal. The tissue-engineered construct was imaged daily using a 
fast-spin-echo sequence, the T1-relaxation time was recorded using a saturation recovery 
spin-echo imaging sequence, the T2-relaxation time was recorded using a spin-echo-
imaging sequence, while the apparent diffusion coefficient was measured using a 
diffusion weighted imaging spin echo based sequence. For the single slice fast spin-echo 
(FSEMS) the following parameters were used: 2000 ms repetition time (TR), 20 ms echo 
spacing (ESP), 4 echo train length (ETL), 256
2 
image matrix, 1 mm slice thickness, and 
25 mm square field-of-view (FOV), and 64 averages (NEX). T1 was measured in seven 
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steps with minimal echo time (TE = 9 ms), TRs of 50, 100, 200, 500, 1000, 2000, and 
4000 ms, and 128
2 
 image matrix .The spin-echo sequence was acquired with a similar 
FOV and slice thickness and the following parameters were used: 4000 ms (TR), 10 ms 
echo time (TE), 64 equal spacing echoes, and 128
2
 image matrix. Finally, ADC data were 
generated by acquisition of a series of spin-echo- diffusion-weighted images. TR = 1000 
ms; TE = 27.04 ms. The diffusion gradient was applied in the readout direction with 12 
b-values of 0-1200 s/mm
2, diffusion gradient duration (δ) of 3 ms, and a separation (Δ) of 
18 ms were used. For quantitative MR analysis, T1,T2 , and ADC were extracted and 
averaged over the entire construct from the experimental data using a least squares single 
exponential fitting implemented by MATLAB ( MathWorks inc., Natik, MA) [1]. All 
quantitative data were expressed as the mean ± standard deviation of all the pixels within 
the construct. 
4.2.6 Histology 
Following 4 weeks of growth in vitro, the e-incubator specimen along with the 
osteogenic construct grown in the incubator, were cut in half, rinsed with PBS, with half 
placed in 10% buffered formalin. The remaining half was used for live-dead assay. 
Constructs were then embedded in paraffin and sectioned. Sections were stained with 
hematoxylin and eosin (H&E) and von Kossa to examine mineralization and calcium 
deposition. 
4.2.7 Live-dead assay 
The remaining half of each tissue construct was treated with a LIVE/DEAD 
Viability/Cytotoxicity Kit (Invitrogen, Carlsbad, CA) used according to the manufactures 
instructions. Briefly, PBS rinsed constructs were placed in the calcein/ethidium bromide 
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mixture for 1 hour, then rinsed and viewed on an Inverted Confocal Microscope IX81 
(Olympus, Lehigh, PA). Live cells emitted fluorescent green and dead cells show red. 
Comparisons were made between the e-incubator and standard incubator cultured 
constructs. ImageJ Software (NIH) was used to count the live/dead cells and comparisons 
were made between both constructs.    
4.3 Results 
A feasibility study was initially conducted in order to confirm that the e-incubator 
mechatronics inside the magnet did not affect MRI sensitivity in detecting bone 
formation. The data from this preliminary study are presented in Figure 4-2. The viability 
and growth of the construct was validated using MRI. The lower signal intensity in the 
construct at week two suggests increased mineralization [Figure 4-2b vs. Figure 4-2a]. 
Additionally, Figure 4-2c demonstrates that the temperature, pH, and CO2 were adjusted 
automatically and recorded continuously during the culturing process.  
 
Figure 4-2 Preliminary results of a smart incubator prototype using hMSC and a 
gelatin scaffold. Axial MRI magnitude images of hMSC derived TEB gelatin based 
construct at week 1 (a) and week 2 (b), acquired by a fast spin-echo (FSE) sequence 
with same acquisition parameters; the in-plane resolution is 97 micron square. Note 
that due to media exchange, the position of the construct is slightly different from 
week one to week two. (d) 24-hour time course of temperature (maintained at 
around 37 
o
C), pH, and CO2 (5%) inside the TI chamber. The sharp drops of CO2 
represent media exchange, which is scheduled to occur once every six hours. 
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Data analysis revealed a temperature mean of 36.1 C, a CO2 concentration of 5.24%, and 
a pH level of 8.25 for the e-incubator. The data was processed to view sampling at every 
10 minutes. During the media changes every six hours, the temperature reading decreased 
because the temperature probe was no longer in media. Furthermore, CO2 decreased as 
the gas was turned off to prevent cooling. 
 
Figure 4-3 Culturing tissue engineered bone for four weeks in the e-incubator. (a) 
Daily MR magnitude images of hMSC derived TEB silk based construct cultured in 
the e-incubator for 28 days. Axial MR magnitude images were acquired using a FSE 
with the following parameters: TR = 1 s; ESP = 20 ms; ETL = 4; slice thickness = 
0.5 mm; FOV = 2.3 cm square; in-plane resolution = 62.5 μm × 62.5 μm; NEX = 8. 
(b) Generated graphs of the daily MR parameters: T1, T2, and ADC for TEB silk 
based construct for 28 days of tissue development. For each sample, T1, T2, and 
ADC decay curve consisting of signal versus TR, TE, or ‘b’ values were extracted 
from the entire TEB construct. All data are presented by averages ± standard 
deviation of the values within the constructs. (c) The fluorescence micrographs for 
the e-incubator construct treated with the live/dead assay express viable cells green 
and non-viable cells red, similar to the control construct cultured in standard 
incubator (data not shown). Scale bar = 50 microns. 
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Following the feasibility study, a protein silk based TEB construct was grown in 
the e-incubator for four weeks. Daily MR magnitude images are presented in Figure 4-3a. 
The corresponding daily acquired MR parameters including T1 and T2 relaxation times 
and apparent diffusion coefficient (ADC) are presented in Figure 4-3b. Following four 
weeks of culturing inside the magnet, cell viability inside the construct was confirmed 
using a scanning laser confocal microscopy for both the e-incubator and the control 
incubator tissues. The live/dead staining assay was used to label the viability of the 
hMSCs. Calcein-AM dye stained live cells green, and ethidium homodimer dye stained 
dead cells red. Confocal micrographs showed that the majority of cells for all groups 
were alive and visible with equivalent staining of live/dead cells in the osteogenic groups 
for the constructs grown in both the incubator and e-incubator, as shown in Figure 4-3c.  
The T2 relaxation times reduced from 118 ms on week 0 to 90 ms on week 4 (20 
% reduction) which was notably different than the results shown for gelatin based TEB 
measured previously [1]. These results initiated a comparison study between gelatin and 
silk based TEB constructs. The culture chamber was modified to hold two constructs 
grown simultaneously in the e-incubator. Sample MR magnitude images are shown in 
Figure 4-4a. The corresponding daily measured MR parameters are presented in Figure 4-
4b. There was only a significant difference between the measured T2 times between the 
two TEB constructs (reduced from 117 ms on week 0 for both constructs to 95 ms and 60 
ms for gelatin and silk base constructs, respectively). Finally at the end of the four weeks 
culture period, comparative histology for the gelatin and silk constructs grown in a 
standard incubator and the e-incubator was performed as shown in Figure 4-4c. The 
histologic slides of both groups grown in the e-incubator and incubator were similar with 
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a lightly increased mineralization for the e-incubator group over the incubator group as 
demonstrated by the larger number of black stains on the von Kossa slides.  
 
Figure 4-4 Comparing the development of two tissue engineered bone constructs 
grown simultaneously in the e-incubator. (a) Sample MR magnitude images of TEB 
silk and gelatin based constructs cultured in the e-incubator for 28 days. Axial MR 
magnitude images were acquired using a FSE with the following parameters: TR = 
1 s; ESP = 20 ms; ETL = 4; slice thickness = 0.5 mm; FOV = 2.3 cm square; in-plane 
resolution = 62.5 μm × 62.5 μm; NEX = 8. (b) Graphs of the daily MR parameters: 
T1, T2, and ADC for TEB constructs in a silk scaffold (triangles) and gelatin 
(squares) for 4 weeks of tissue development. (c) Comparative histology for the TEB 
gelatin and silk based constructs grown in a standard incubator and the e-
incubator. H&E histology displayed nuclei stained blue/violet, cytoplasm purple, 
and collagen pink (column 1). The von Kossa staining indicated mineral deposits 
with black stain (column 2). Scale bar = 50 microns.  
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4.4 Discussion 
A feasibility study was initially conducted in order to confirm that the This study 
demonstrates the feasibility of growing tissue-engineered constructs inside the e-
incubator while continuously monitoring and assessing growth via MRI and using 
different scaffolds and culturing methods. Importantly, the electronics of the e-incubator 
do not reduce the quality of the MRI data collected. In gelatin-based constructs, 
osteogenesis reduces the values for the T2-relaxation time by 60% due to ECM 
mineralization. The T2 values are correlated with osteogenic markers, including ALP 
activity in a previous study [1]. For the gelatin based TEB, the T2 was approximately 120 
ms at the beginning of tissue culture and reduced to approximately to 65 ms after four 
weeks of culture. In a previous study measuring T2 relaxation time, the T2 values reduced 
from 67 to 24 ms (approximately 60% for both methods), reduced measured values are 
due to the stronger magnetic field (11.74 T compared to 9.4 T) which reduces the 
measures T2 relaxation times. 
However, the previous study was performed at discrete time points where 
constructs were sacrificed weekly. In our study, the e-incubator offers prolonged 
assessment of the same construct, which reduces data inconsistency and scattering due to 
sampling and dramatically reduces statistical power during hypothesis testing. 
Importantly, the ability to conduct continuous MRI assessment is expected to allow for 
the investigation of different MRI contrast mechanisms (e.g., mechanical measurement, 
diffusion, spectroscopy, magnetization transfer ratio, etc.) and link these contrast 
mechanisms to the structure, composition, and function of tissue-engineered constructs. 
Having such capability has the potential to speed the translation of tissue-engineered 
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products to the clinic. Additionally, such a device can provide critical clinical 
applications because it offers the opportunity for an intervention. For example, changing 
the culture environment through the replacement of growth medium or the introduction of 
mechanical forces through shear flow is highly feasible. 
To study the effect of scaffold type on osteogenesis, we cultured osteogenic 
constructs in both silk- (~500 µm pores) and gelatin- (~250 µm pores) based scaffolds 
simultaneously in an e-incubator study for four weeks. Only the T2 value was different 
between the two constructs. The T2 was selected as an indicative MRI parameter and it 
was previously correlated with ALP activity [1]. The T2 was approximately 120 ms for 
both constructs at the beginning of tissue culture and reduced to approximately to 90 ms 
for the silk-based construct and 65 ms for the gelatin-based construct. We concluded 
from this study that MRI parameters are dependent on scaffold type, primarily due to the 
variation in porosity. This can also be seen on the histologic slides where even though 
bigger chunks of black stains, indicating mineral deposition, can be noticed on the silk 
scaffolds, higher deposited quantities can be noticed on the gelatin scaffolds. 
The detailed imaging assessment technique is expected to provide a basis for 
creating high-quality, tissue-engineered constructs by non-destructively identifying 
molecular fingerprints in constructs and selecting suitable constructs with the osteogenic 
phenotype for implantation. Throughout the culture period, certain molecular markers are 
expected to be expressed, along with osteogenic differentiation in MSC-derived tissue-
engineered bone constructs cultured in the e-incubator. For example, OPN expresses in 
the early stage of developing bone cells prior to mineralization or OCN expression [196]. 
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Therefore, future studies can be used to correlate MR findings with different osteogenic 
markers.  
Limitations of the e-incubator include the physical regulatory effects of magnetic 
fields (static and gradients) on cells. It is possible that the high-field MR will influence 
the development of constructs if the tissues are constantly retained inside the MRI 
scanner; the physical regulatory effects of MR (strong magnetic field) on cells are not 
well understood. Similarly, one particular study reported that magnetic and electrical 
fields may alter osteoblastic proliferation and differentiation [197]. In future studies, if 
the growth of tissue-engineered bone is affected, then the e-incubator should only be 
placed inside the magnet during imaging sessions. On the other hand, if the presence of 
the magnetic field and alternating imaging gradients affects osteogenesis, imaging 
sessions duration should be optimized to enhance engineering outcome. In our future 
studies, we will examine the effect of the alternating magnetic field gradients, as well as 
compare different scaffolds. Importantly, the model of a MRI-compatible incubation 
system used for culturing tissue-engineered bone constructs may help create other 
culturing systems for other biological tissues such as tissue-engineered cartilage [198] 
and neural stem cells [199].  
Integration of the e-incubator with MRI can potentially allow for the 
establishment of critical check points to identify osteogenic markers that confirm the 
stability of the phenotype and genotype prior to implantation. In turn, the e-incubator 
with MRI capability is expected to increase the success rate for tissue-engineered 
constructs through its ability to filter deficient constructs. This is particularly applicable 
in the ability of the e-incubator to help monitor and steer tissue-engineered bone 
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constructs designed for unique needs of individual patients. Overall, this application has 
the potential to advance tissue-engineered bone techniques to clinical practice. 
Furthermore, while bone is used as a model system, the e-incubator itself is expected to 
have applications in a range of tissue-engineered constructs, including skin, organ tissue, 
and even tumorigensis and cancer treatment. 
The increasing use of bioreactors in tissue engineering indicates that control and 
manipulation of the culture environment becomes as important as the choice of cell or 
scaffold. Future design should incorporate physiological mechanical stress into the e-
incubator system to create a bioreactor for bone tissue engineering. Perfusion flow and 
micro-mechanical ultrasound stress can both be used to transform the e-incubator to an 
MR compatible bioreactor [200, 201]. The e-incubator can be integrated with multiple 
imaging modalities, thus providing different contrast mechanisms and spatial resolution. 
For example, the e-incubator has the potential to improve our understanding of 
tumorigenesis by providing continuous assessment of cellular to organ levels during this 
process. Similarly, as the e-incubator could be used to continuously assess therapeutic 
efficacy. Thus, the e-incubator has the potential to transform practices in multiple 
biomedical sciences ranging from tissue engineering and regenerative medicine to cancer 
research.  
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CHAPTER 5 
 
MONITORING BONE REPAIR IN A MOUSE CALVARIAL DEFECT MODEL USING 
MULTIMODAL IMAGING 
 
5.1 Introduction 
Treatment of bone disease and/or severe bone damage typically involves the use 
of bone grafts and surgical reconstruction. Still, several difficulties can arise from bone 
grafts, including morbidity at the donor site, infection, immune system reactions, and 
exposure to infectious agents [202]. To overcome difficulties associated with bone grafts, 
researchers have long been investigating the potential of tissue-engineered alternatives. 
To engineer bone tissue, a combination of cells, a biocompatible scaffold, and signaling 
molecules are used to create bone substitutes [24].  
Evaluating in vitro data from tissue-engineered bone (TEB) studies allows for 
extraction of useful information, but the experimental conditions cannot be truly 
replicated in the in vivo environment. Hence, animal models are critical to assess the 
biological activation of osteogenesis, osteoconduction, osteoinduction, mass transport, 
and biophysical effects during bone regeneration [203, 204]. Importantly, one widely 
used model to study bone regeneration is the critical-sized calvarial defect mouse model, 
for which naturally regenerated bone occurs at a rate of less than 10% during the lifetime 
of the animal [205]. This model is of particular value for studying the development of 
TEB in native conditions and the ability of TEB to promote repair of a discontinuous 
lesion [204]. Notably, the defect site has easy surgical access, requires no fixation, and 
creates a uniform, easily reproducible, standardized defect [204]. Calvarial defect studies 
are performed using a broad range animal models including mice [206], rats [207], 
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rabbits [208], or large animals including dogs [209], sheep [210], or pigs [211]. Large 
animal models are of greater clinical relevance given that their skeletal maturity more 
closely resembles that of humans [203].  
Currently, most related experiments assess the development of engineered tissue 
throughout the course of the study at predetermined intervals. Animals are sacrificed for 
each examination time point in order to compare changes in longitudinal growth [37]. 
Excised tissues from the sacrificed animals are subjected to histology, 
immunohistochemistry (IHC), real-time polymerase chain reaction (RT-PCR), and micro 
computed tomography (μCT) [38-40]. In order to reduce the number of animals necessary 
for statistical significance and reduce data scattering, a non- and/or less-invasive 
alternative is needed that does not require animal sacrifice. 
Imaging modalities, such as ultrasound, computed tomography (CT), near-
infrared (NIR) optical imaging, and magnetic resonance imaging (MRI), are non-
destructive, permitting serial observations at discrete time points on the same animal. For 
example, ultrasound is suitable for early stages of detecting bone regeneration, but mature 
bone cannot effectively be penetrated with acoustic waves [41]. CT, on the other hand, 
provides 3-D structural images with high spatial resolution and penetration depth and is 
clinically translatable for late stages of regeneration through assessing the integration and 
connectivity of TEB with the host bone tissue. However, CT has limited sensitivity for 
pre-mature/immature bone and bone-like tissues. Also, the radiation from CT has been 
found to suppress growth and induce breakdown in mouse bone [37, 42]. On the other 
hand, molecular optical imaging relies on a source of contrast from fluorescence, 
bioluminescence, absorption, or reflectance [212] . Fluorescently-labeled targeted probes 
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that emit signals in the NIR region (700-900 nm) of the spectrum utilize lower tissue 
absorption coefficients and result in deeper light penetration compared to imaging at 
visible wavelengths. Alternatively, bioluminescence imaging utilizes luciferase gene 
expression systems that emit visible photons based on energy-dependent reactions 
catalyzed by luciferases. For example, Degano et al. (2008) used bioluminescence to 
study calvarial bone repair in a mouse defect model based on manipulation of the cells 
for gene insertion, verification of gene expression, and expansion of the cells with gene 
expression [213]. In a previous study of TEB implanted in a subcutaneous mouse model, 
NIR dye-labeled targeting agents, IRDye® 800CW BoneTag
TM
 (800CW BT), targeted 
mineralized bone or hydroxyapatites and effectively identified bone growth [214]. 
Relatedly, MRI provides high spatial resolution and detects changes in the water content 
of tissue, thus revealing alterations of the structure and/or functions [37]. Although each 
imaging modality provides information on the tissue engineering process, no single 
imaging modality fully characterizes the complex remodeling process of TEB.  
This paper presents a feasibility study for the application of noninvasive multi-
modal imaging, MR and optical imaging, to assess TEB that is implanted into a critical-
sized (5 mm) calvarial defect mouse model. Each mouse served as its own control, with 
the contralateral side of the cranium was grafted with a silk protein implant without cells. 
NIR optical imaging with 800CW BT and MRI were used to evaluate the implant 
environment for bone regeneration and/or mineralization in vivo for six months. At three 
time points (i.e., two, four, and six months post implantation) implants were harvested 
and analyzed using histology. CT was used to assess the regeneration at study completion 
for one representative mouse. 
67 
 
  
 
 
5.2 Experimental 
5.2.1 Tissue-Engineered Bone (TEB) 
Human mesenchymal stem cells (hMSCs), isolated from fresh adult human bone 
marrow obtained commercially (Lonza, Walkersville, MD) were suspended in growth 
medium in a T-75 flask. The medium was composed of Dulbecco’s Modified Eagle’s 
medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen, Carlsbad, CA), and 0.5% antibiotic/antimycotic (Sigma-Aldrich, St 
Louis, MO), and placed at 37
0
C and 5% CO2. The media was changed twice weekly, and 
cells were passaged up to five times prior to seeding. Aqueous protein silk sponges with a 
pore size of 400-500 μm, a diameter of 5 mm, and a thickness of 2-3 mm, were prepared 
as previously reported [194]. The sponges were next autoclaved, placed in the medium 
described above, and conditioned for at least four hours. Following this, two silk 
scaffolds were placed in a 24-well plate and seeded with hMSCs at a density of 1 million 
cells in 35 μl of medium. Following two hours of incubation, osteogenic growth medium 
containing DMEM, 10% FBS, 0.5% antibiotic/antimycotic, 100 nM dexamethasone, 10 
mM, β-glycerophosphate, and 0.05 mM ascorbic acid 2-phosphate (Sigma-Aldrich) was 
added to the wells. TEB was cultured in osteogenic media for two weeks prior to 
implantation. On the day of surgery, sterile silk scaffolds and TEB were thinly sliced < 1 
mm, placed in phosphate buffered saline (PBS), and maintained in sterile conditions at  
37 
0
C until surgical insertion.  
5.2.2 Mouse Critical-Sized Calvarial Defects 
All animal procedures were performed using protocols approved by the 
Institutional Animal Care and Use Committee at the University of Nebraska - Lincoln 
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(UNL). Following UNL guidelines for animal usage, five 8-week-old male nude 
immunodeficient mice (n = 5) (nu/nuJ; Jackson Laboratories, Bar Harbor, ME) were 
anesthetized using 2% isoflurane. An iodine solution scrub was used to sterilize the 
surgical area prior to surgery. A sagittal midline incision was performed to reveal the 
underlying bone, and the periosteum was removed. A 5 mm stainless steel trephine (Fine 
Science Tools, Foster City, CA), attached to a drill (Dremel, Racine, WI), generated two 
contralateral defects per animal, one on each side of the calvarium (Figure 5-1) [38].  
 
Figure 5-1 Schematic drawing of mouse calvarial defect for surgical insertion of silk 
scaffold (left side) and tissue-engineered bone (right side) implants. 
Care was taken to ensure the dura remained intact during drilling and calvarium removal. 
Forceps were used to place the silk scaffold and TEB on the left and right defects, 
respectively. Using nylon surgical sutures, the incision was closed, and the animal 
removed from isoflurane exposure. Following surgery, mice were maintained under 
aseptic conditions. Sutures were removed at one week post-surgery. Each animal served 
as its own control, with the silk scaffold implant serving as the control to the TEB 
implant. Of the five animals, one animal was sacrificed and evaluated at month 2, another 
animal was sacrificed and evaluated at month 4, and three animals were sacrificed and 
evaluated at month 6. 
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5.2.3 Near-Infrared Optical Imaging 
All mice were anesthetized with 2% isoflurane inhalation for all imaging 
procedures. The NIR dye-labeled targeting agent 800CW BT (LI-COR Biosciences, 
Lincoln, NE) was reconstituted to a dose of 2 nM per animal according to the 
manufacturer’s instructions; each mouse received a 100 μl intraperitoneal injection. NIR 
optical images were acquired using the Pearl
®
 Impulse Small Animal Imaging System 
(LI-COR Biosciences, Lincoln, NE). Pre-injection dorsal images (85 μm) of the mice 
were acquired 24 hours post-surgery and at one-month intervals, starting at one-month 
post-surgery and continued for six months. Each month, following baseline imaging, 
mice were injected intraperitoneally with 800CW BT and imaged 48 hours post-injection 
to allow the unretained agent to clear. For imaging at months four through six, the 
implant site was shaved and treated with the depilatory cream Nair™ (Church and 
Dwight Co, Inc., Ewing, NJ) to prevent interference from hair growth. Prior to month 
four, hair growth was minimal. Relative fluorescent units (RFUs) for the silk scaffold and 
TEB implants were recorded for each animal by placing a region of interest (ROIs) on the 
defect area and analyzing it using Pearl Cam Software (LI-COR Biosciences, Lincoln, 
NE). 
5.2.4 Magnetic Resonance Imaging 
Prior to MRI, mice were anesthetized and positioned on a custom-designed 
animal holder (Agilent, Inc., Palo Alto, California). Throughout imaging, animals were 
maintained under anesthesia (1.2%-2% isoflurane), with their body temperature and 
respiration rate closely monitored and controlled using the Model 1025 Monitoring and 
Gating System (SA Instruments, Stony Brook, NY). Both in vivo and ex vivo anatomical 
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images of the tissue-engineered constructs were acquired using a 9.4 T, 89 mm vertical-
bore magnet (Agilent, Santa Clara, CA). For the in vivo imaging, images were acquired 
with a 4-cm millipede radiofrequency (RF) coil. Micro-imaging triple axis gradients 
(Agilent, Santa Clara, CA) with a maximum strength of 100 Gauss/cm and inner diameter 
of 57 mm were used for all experiments. The scanning protocol first obtained gradient-
echo axial slices using repetition time (TR) = 300 ms, echo time (TE) = 2.5 ms, flip angle 
= 25°, field-of-view (FOV) = 24 cm, and slice thickness = 0.3 mm sectioned through the 
defect site to localize the constructs. Following localization, slices were obliquely aligned 
orthogonal to the axial slices and tangentially to the constructs. The appropriate plane 
was chosen to acquire a fast-spin-echo sequence (FSEMS) with the following parameters: 
repetition time (TR)/echo spacing (ESP) = 2000/9.39 ms, echo train length (ETL) = 8, 
number of averages = 16, FOV = 23 mm
2
, matrix size = 128
2
, slice thickness = 0.2 mm 
and imaging time = 8 min and 36 s. Animals were imaged at zero, one, three, and six 
months. Comparisons were made between the cranial images of the silk scaffold and the 
TEB. 
At six months post-surgery, one mouse was sacrificed; the head was fixed in 
10%-buffered formalin and imaged using the parameters listed above followed by CT 
imaging (described below). Following the imaging of the fixed head, the implants were 
excised, placed in formalin, and imaged with a 10 mm RF coil. To increase the signal-to-
noise ratio, a 10 mm, custom-designed RF coil was used in combination with a magnet. 
To acquire high-quality images with a short echo time (TE), a gradient-echo sequence 
was employed to contrast the silk scaffold and TEB. The applied parameters for the 
gradient-echo sequence were TR = 500 ms, TE = 3.19 ms (minimum); flip angle = 25º, 
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number of averages =16, FOV = 21 mm
2
, matrix size = 128×128, slice thickness = 0.2 
mm, and imaging time = 4 s and 17 min. MRI magnitude images were compared to 
calculate the difference in signal intensity for the silk scaffold and TEB. 
5.2.5 Computed Tomography 
After six months of regeneration, the head of one representative mouse was 
decapitated and fixed. The entire cranium/head was imaged using CT. Image acquisition 
was accomplished using a FLEX Triumph X-ray computed tomography/single photon 
emission system (CT/SPECT) (Gamma Medica, Inc., Salem, NH). Data was analyzed 
using software (TriFoil Imaging, Inc., Northridge, CA) to assess the extent of the 
regeneration after six months, and 1,024 CT projections with three frames per projection 
were acquired at 60 kVp and 210 µA with a focal spot size of 50 µm. These CT/SPECT 
projections were reconstructed at an optimum resolution option using Triumph X-O 4.1 
(Gamma Medica, Inc, Salem, NH). The matrix size was 512 µm, and the voxel size was 
180 µm. Images were generated using visualization and analysis software VIVID, which 
is based on Amira 4.1 (Visualization Sciences Group, Germany). 
5.2.6 Histology 
At two-, four-, and six-month intervals, an animal was sacrificed, and the tissue 
was excised from each defect site. Samples were fixed in 10%-buffered formalin and 
processed for paraffin embedding at the UNL Nebraska Veterinary Diagnostic 
Laboratory. Samples were sectioned (5 μm) and stained with hematoxylin and eosin or 
von Kossa stain. All slides were examined by a certified pathologist and imaged with a 
light microscope AX70 (Olympus, Center Valley, PA).  
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5.3 Results 
5.3.1 Optical Imaging 
At 72 hours after surgery and 48 hours after 800CW BT dye injection, NIR 
optical imaging revealed probe retention. The data was excluded at month zero because 
inflammation at the defect sites biased the optical images. At the one-month time point, 
defects were clearly visible in all mice (n = 5) with the TEB, displaying higher signal 
intensity (RFUs) than the control implant. During the entire bone development period, 
defects were clearly visible in all mice, with the TEB implants displaying higher RFUs 
than the silk scaffold control implants. The strongest signal intensity occurred at month 
two. Figure 5-2 presents the NIR optical images of a mouse at one-month intervals, 
ranging from one to six months. It should be mentioned that pre-injection baseline 
imaging did not occur for month one, and the data from that month could not be used for 
quantitative but rather for qualitative representation. ROIs (Figure 5-2; circles) indicate 
the ROI for assessing bone growth/mineralization. The control (left side) and the TEB 
(right side) were analyzed to determine the binding of 800CW BT (Figure 5-3).  
 
Figure 5-2 Near-infrared optical images for study mouse at one-month intervals, 
starting at month 1 up to 6 months. The images at each interval were taken at 48 
hours post-injection. Circles indicate the region of interest (ROI) examined for 
intensity of relative fluorescent units (RFU). The left circle indicates the site of silk 
scaffold (i.e., control), and the right circle indicates the tissue-engineered bone 
(TEB) implants. 
At month two, the data revealed peak fluorescence for TEB, with RFU = 0.66. There was 
a constant RFU for months three through five (RFU = 0.59, 0.57, and 0.58, respectively) 
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and a decline to 0.44 at month six. Along with peak fluorescence at month two of 
imaging, all mice exhibited a higher deposition of 800CW BT in the TEB compared to 
the control. 
 
Figure 5-3 Evaluation of the region of interest (ROI) showing the relative 
fluorescent units (RFU) for pre-injection and 48 hour post-injection for defect sites, 
starting at month 2 up to 6 months. 
5.3.2 MRI and CT 
5.3.2.1 In Vivo Imaging  
MRI of the control and TEB implants were acquired at three time points during 
the study. Figure 5-4a illustrates how the slice was aligned for imaging of the defect sites. 
MRI magnitude images of the control and TEB implants are shown in Figure 5-4b, where 
images from the same mouse are shown for different growth stages are shown. With 
respect to regeneration, both implants exhibited a decrease in signal-to-noise ratio (SNR). 
The control SNR was higher compared to the TEB, however, the control SNR also 
decreased as the study proceeded.  
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Figure 5-4 MRI magnitude images of the control and TEB constructs at three time 
points. (a) Alice alignment: Images were acquired in oblique planes touching the 
constructs and cutting through them with a slice thickness of 0.3 mm. (b) MRI 
magnitude images of the control and TEB constructs at different growth stages 
acquired using a fast-spin-echo (FSE) sequence. The constructs are outlined by 
white dashed contours. Gated Images show that the decrease in the MR SNR for the 
TEB construct is more than the control. Acquisition parameters were TR=2000 ms; 
ESP=9.39 ms; ETL=8; Average=16; Matrix=128
2
; FOV=23 mm
2
; acquisition time= 
8min and 36 sec. 
5.3.2.2 Ex Vivo Imaging 
After six months of regeneration, one mouse (out of three) was sacrificed; the 
head was removed and placed in 10% buffered formalin. Figure 5-5a shows the control 
and the TEB implants in the fixed mouse head. Both implants appear integrated with the 
native tissue. However, the CT image (Figure 5-5b) revealed the control implant covered 
approximately 40% of the defect site, while the TEB covered approximately 80% of the 
defect site. MRI magnitude images (Figure 5-5c and d) resulted in a SNR of 11.6 for the 
TEB and 26.5 for the silk scaffold, indicating greater mineralization in the TEB implant. 
Higher quality MRI magnitude images were acquired by excising the constructs and 
capturing images using the 10 mm RF coil as shown in Figure 5-6. The resultant MRI 
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magnitude images acquired by a gradient echo sequence illustrated significant difference 
(SNR of 11.6 compared to 26.5) between the signal intensity of TEB compared to the 
control, as shown in Figure 5-6. 
 
Figure 5-5 (a) Photograph of excised, fixed mouse head after 6 months of in vivo 
growth. (b) CT image of fixed mouse head at study completion showing the implants 
for the silk scaffold control and the tissue-engineered bone (TEB). High resolution 
magnetic resonance imaging (MRI) magnitude images of the (c) control and (d) 
TEB. The control had a high SNR (SNR = 26.5) compared to the TEB (SNR = 11.6). 
2Images were obtained with a 40 mm RF coil. TE = 3.19 ms; Flip angle = 25; 
Average = 16; Matrix = 128
2
; Slice thickness = 0.2 mm. The implants are outlined by 
white dashed circles, and the SNR is indicated on each image. 
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Figure 5-6 High-resolution magnetic resonance imaging (MRI) magnitude images of 
the excised tissue samples upon conclusion of the study after six months. White, 
dashed circles outline the (a) Control and (b) tissue-engineered bone (TEB). Due to 
mineralization of the tissue, the TEB produced a lower signal-to-noise ratio (SNR) 
compared to the control. For imaging, a 10 mm RF coil was used with acquisition 
parameters for the applied gradient–echo sequence imaging as follows: TR = 500 
ms; TE = 3.19 ms; Flip angle = 25; Average = 16; Matrix = 128*128; Thickness = 0.2 
mm; FOV = 17 min and 4 sec. 
5.3.3 Histology 
Mice were sacrificed at 2 (n=1), 4 (n=1), and 6 months (n=3). The calvarial 
implants were excised, and the tissue was processed for histological analysis. 
Hematoxylin and eosin stain was used to evaluate the composition and structure of the 
implants; von Kossa was used stain to evaluate mineralization (Figure 5-7). Observations 
using light microscopy showed the control implant underwent some cell migration from 
the surrounding tissue, but with a large amount of un-degraded silk scaffold visible 
(Figure 5-7a). In contrast, the stained sections of TEB at month 2 (Figure 5-7d) revealed 
numerous cells and the presence of de novo bone. With respect to von Kossa stain at 
month 2, there was minor staining in the control (Figure 5-7g) but an abundance of black 
staining for calcium salts in the TEB (Figure 5-7j).  
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Figure 5-7 Histological analysis of (A-C and G-I) control, (D-F and J-L) of tissue-
engineered bone (TEB) from excised calvarial defects at months 2, 4, and 6. (A-F) 
Hematoxylin-eosin stained sections and (G-L) von Kossa stained sections. Black 
arrows indicate un-degraded silk scaffold, asterisk indicates de novo bone, and blue 
arrows indicate mineralization. Scale bar = 100 
The control for the mouse sacrificed at month 4 incurred an infiltration of cells 
and was less porous than month 2, but had a similar amount of un-degraded silk scaffold 
(Figure 5-7b). The month 4 TEB (Figure 5-7e) demonstrated more new cells than month 
2 and more de novo bone. Similarly, for the control, the von Kossa stain at month 4 
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revealed more calcium salts compared to the month 2 sample (Figure 5-7h), and the TEB 
appeared similar in structure to the month 2 sample (Figure 5-7k). Month 6 staining of 
the control demonstrated cell infiltration, which appeared similar to the previous samples 
(Figure 5-7c). The TEB showed cells and de novo bone, but a decreased amount of both 
compared to previous months (Figure 5-7f). The von Kossa staining at month 6 for the 
control (Figure 5-7i) had a similar amount of calcium deposition as month 4. Also, the 
TEB at month 6 exhibited less calcium salts compared to month 4 (Figure 5-7l).  
5.4 Discussion 
The aim of this study was to evaluate the feasibility of applying multi-modal 
imaging in order to noninvasively assess in vivo growth of a pre-cultured TEB in a 
critical-sized defect mouse model. Noninvasive imaging modalities of NIR optical 
imaging using 800CW BT and MRI, as well as endpoint measurements of histology and 
ex vivo CT, were used to analyze the bone growth and mineralization. This study is 
unique in that it maintained the implants for six months in vivo, and the serial images 
obtained with both modalities confirmed changes in the TEB growth and mineralization. 
Histological findings for bone formation specifically supported the NIR optical imaging 
findings, showing a decrease in bone growth as in vivo development progressed to six 
months. This decrease suggests additional strategies are needed to optimize the 
regeneration process and improve vascularization. For example, more sophisticated 
culturing techniques may be applied to incorporate cross-talk between MSCs and 
hematopoietic stem cells (HSCs) for optimal growth and vascularization [215]. Most 
studies on TEB implanted into a mouse critical-sized calvarial defect model take place 
for only up to 12 weeks [38, 213, 216, 217]. In our study, a significant regeneration of the 
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TEB was identified after two months of culture, similar to most studies, but continuous 
monitoring on the regeneration process up to six months showed an unexpected plateau, 
and even decrease, of NIR optical imaging signal intensity in the TEB. This implies that 
eight weeks may not be a sufficient time frame to fully evaluate and assess the TEB 
regeneration process. 
For NIR optical imaging, mice were administered a NIR-labeled agent, 800CW 
BT, which is specific to bone tissue, and imaged at one-month intervals. This technique is 
ideal for evaluating mouse calvarial defects because the defect site is only a few 
millimeters in depth, and thus, the light absorption and scattering of NIR waves are 
reduced compared to visible wavelengths, enabling noninvasive analysis of the bone 
remodeling and mineralization [218, 219]. The 800CW BT used in this study was 
previously evaluated with an assay to compare undifferentiated hMSCs and an 
osteogenically differentiated hMSCs in a monolayer. In this previous evaluation, results 
showed preferential binding and statistical significance, with the signal intensity 4.45 to 
7.75 times higher for the differentiated cells. Such results were confirmed with positive 
calcium staining using von Kossa [220]. In our study, all animals at all intervals 
demonstrated a higher RFU signal in the TEB than compared to the control; the RFU 
peaked at month 2. The results from the NIR optical imaging of calvarial defects showed 
mineralization in the TEB implant, which also peaked at month 2; however, the signal 
intensity from the animals sacrificed at month 6 were not consistent. We posit that these 
findings resulted from the quality of the TEB samples. In order to optimize the TEB 
implant, it may be necessary to use an improved cultivation system for pre-implantation 
growth, as well as culture the TEB for more than two weeks. For example, Meinel et al. 
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used a bioreactor to provide dynamic culture conditions for tissue-engineered constructs 
for five weeks prior to implantation in mouse calvarial defect model. This strategy 
resulted in the improved generation of a trabecular-like network in the TEB implant [38].  
To compare the signal intensity of the control and TEB implants, MRI was used 
to evaluate the calvarial defect implants noninvasively at specific time points. Compared 
to NIR optical imaging, MRI magnitude images indicated decreased signal intensity 
between TEB and control implants at each imaging interval. Additionally, the intensity 
decreased between the intervals (e.g., at month 0, TEB and control SNRs were greater 
compared to month 3). Previously, MRI was successfully used to monitor in vitro growth 
of TEB, showing a statistically significant decrease in T2-relaxation times from increased 
deposition of minerals and extracellular matrix. Additionally, these results are supported 
by histological findings with von Kossa staining, which indicated extensive calcium 
deposition [1]. Results reinforce that MRI can be used to assess bone growth in an in vivo 
mouse calvarial defect model. Notably, MRI results were in alignment with NIR optical 
images up month 2. However, the MRI SNR of the TEB and the control continued to 
decrease following month 2. This SNR decrease can be interpreted as non-specific 
calcified tissue development within the TEB and the control. X-ray diffraction has been 
used to assess the crystalline nature of the deposited bone tissue in TEB in vitro [38] and 
should be applied in future in vivo studies where implants can be extracted to assess the 
quality of mineralization. Preliminary CT data demonstrated that the TEB implant 
covered a larger area of the defect compared to the control. However, segmentation 
algorithms are needed to differentiate mineralized from non-mineralized tissues [38].  
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The control and TEB evaluated in a critical-sized calvarial defect showed 
apparent histological differences between the observed animals. For example, the 
osteogenic implant showed an abundance of cells, with the most visible at the month 4. 
The control had some cellular integration from the surrounding native mouse tissue. The 
TEB showed de novo bone at all intervals of 2, 4, and 6 months. The control exhibited a 
small amount of de novo bone at month 4, suggesting host cells integrated into the silk 
and produced developing bone, which was also supported by mineralization in the von 
Kossa results. The von Kossa results from the TEB corroborated the findings from the 
NIR imaging, showing a peak in bone growth at month 2, with a small decrease for 
months 3-5 and a greater decrease at month 6.  
To improve results obtained from this feasibility study, it is necessary to verify 
and enhance the quality of TEB implanted into the defect model. Use of a spinner flask or 
a bioreactor for the pre-implantation culture is expected to increase the quality of the 
tissue. Additionally, in order to provide an even distribution of hMSCs, improved seeding 
methods could be used for the silk scaffold dimensions rather than the sectioning and 
implanting it immediately prior to surgery. Furthermore, it may be necessary to verify the 
quality of the TEB prior to surgery. Empty defect control with no scaffold can be used to 
compare with TEB regeneration in future studies. Based on this study, fiduciary markers 
are needed to register images acquired via different modalities, and more comprehensive 
TEB evolution can be recorded. The same fiduciary markers can be used for the imaging 
modalities to improve replication of animal positioning as the animals grow.  
 In conclusion, this study demonstrates the feasibility of multi-modal imaging 
using NIR optical imaging and MRI to noninvasively evaluate TEB growth in critical-
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sized calvarial mouse defect implants. With some modifications to the current study, as 
discussed above, these imaging modalities can be used to provide improved results for 
future studies and for translating the new methods to clinical studies. NIR imaging with 
800CW BT can effectively visualize hydroxyapatite (HA), a good biological osteogenic 
marker. MRI was effective for anatomical imaging, as well as for visualization of 
collagen through the identification of different markers using advanced imaging 
techniques, such as the magnetization transfer ratio. Finally, CT with proper threshold 
and segmentation routines can be used to visualize integration and connectivity of TEB 
with the host bone. 
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CHAPTER 6 
 
MRI-GUIDED EVALUATION OF CARTILAGE TISSUE ENGINEERING IN VIVO 
 
6.1 Introduction 
Cartilage abnormalities such as degeneration of the joint's cartilage due to primary 
osteoarthritis, injury to the articular cartilage, inflammation, and genetic disorders affect 
almost 30 percent of Americans [221, 222]. Cartilage is a form of connective tissue, with 
regard to its molecular structure, and consists mainly of water, collagen, proteoglycans, 
and cells [223]. Articular cartilage, specialized to provide a smooth surface for joints, is 
composed of 65-75% water, 14-20% collagen, and 5-15% proteoglycans [223-225]. 
Repair of cartilage defects remains a challenging problem due to the biological features 
of cartilage tissue, such as limited blood supply, lack of self-repair capacity [226] and 
defective immobilization [227]. Tissue engineering and stem cell therapy hold great 
potential of being able to restore, repair, and replace damaged or lost cartilage tissue 
[228]. Human mesenchymal stem cells (hMSCs) have been used successfully to 
differentiate into a wide range of cells, including osteoblasts (bone cells) [229], 
chondrocytes (cartilage cells) [230], and adipocytes (fat cells) [231], depending on 
culture conditions. To regenerate functional tissues and organs, three-dimensional 
scaffolds have to be designed to prepare attachment sites and bioactive signals for growth 
and differentiation of cells into a desired lineage [232]. Collagen (the main constituent of 
skin, cartilage, bone, and connective tissue) and gelatin, which is a derivative of collagen, 
have been widely employed in cartilage tissue engineering as scaffolds [233-236]. 
Another scaffold that has been used for encapsulating chondrocytes in cartilage tissue 
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engineering is highly porous silk scaffold developed by an aqueous process as described 
by Rockwood et al. [237]. Recent works have assessed the efficacy of different scaffolds 
containing embedded chondrocytes or stem cells for cartilage repair [238-240]. Park et al. 
reported cartilage regeneration using biodegradable oxidized alginate/hyaluronate 
hydrogels and effective cartilage regeneration was observed after 6 weeks of 
transplantation based on histological analysis, substantial secretion of sulfated 
glycosaminoglycans, and expression of chondrogenic marker gene (Collagen II) 
compared with non-degradable oxidized alginate/ hyaluronate hydrogels were observed 
[241].   
There is a great need for the development of effective methods for monitoring the 
composition, structure, and function of the tissue-engineered cartilage in vivo. These 
techniques have to be noninvasive and preferably they should provide quantitative 
information at different growth stages, repair, and regeneration. Conventional 
characterization of engineered constructs is carried out with a variety of tools, such as 
microscopy, biochemical assays, and histologic stains. While these methods provide 
critical information on tissue’s regeneration, they are destructive and result in the 
sacrifice of the tested subject [242]. This results in the need to test larger numbers of 
animals to compensate for data scattering in order to derive meaningful conclusions. 
Noninvasive and nondestructive techniques, therefore, must be investigated which enable 
one to both analyze and quantify constructs in vitro and regenerated tissues in vivo. The 
materials and specimens can be evaluated longitudinally in the same animal by means of 
the noninvasive techniques and analyzed by a statistical method for repeated 
measurements. This reduces the number of animals, experiments costs, and allows early 
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intervention and modification of experimental protocols to obtain superior engineering 
outcomes. Biomedical imaging methods such as computed tomography (CT) [243], 
ultrasound (US) [244], and MRI [245-247] are being applied as noninvasive means of 
assessment. Among the imaging technologies, MRI has been shown to potentially play a 
significant role in tissue engineering, providing nonionizing radiation, high spatial 
resolution, high penetration depth, and multiple contrast mechanisms [1]. Researchers 
have employed MRI-based techniques to correlate various MR-derived parameters (e.g., 
transverse MR relaxation time T2, apparent diffusion coefficient (ADC), shear stiffness, 
and magnetization transfer (MT) ratio) with mineral deposition and molecular content [1, 
82, 248, 249]. One recently developed contrast mechanism employs a phase-contrast in a 
technique termed MRE for elasticity imaging [250-253]. MRE requires three steps to 
generate quantitative stiffness maps. First, a mechanical actuator is coupled to the tissue 
of interest to generate propagating shear waves through the tissue. Then, a pulse 
sequence, including a motion encoding gradient (MEG), is used to encode the motion as 
phase in the MR image. Finally, an inversion algorithm is employed to recover the shear 
stiffness map (or elastogram) from the spatio-temporal data. MRE, while relatively new, 
has been extensively developed to characterize the mechanical properties of biological 
soft tissue [254-257], and also has been used for preliminary research in tissue 
engineering [257-259]. MRE was transferred to the microscopic scale using high field 
MRI and was employed to monitor tissue-engineered constructs regeneration in vitro and 
in vivo [257, 260-264]. Mechanical properties acquired using MRE besides conventional 
MRI data, such as T2, ADC, MT ratio, can be expected to play a leading role in assessing 
engineered cartilage. These anatomical, biochemical, and biomechanical features can be 
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extracted at different time points of cartilage growth in preclinical models to generate 
sensitive biomarkers, which can help choose the appropriate time points to be used in 
preliminary clinical trials.   
In the current study, high field MRE and MRI are applied as noninvasive 
techniques to characterize biomechanical and biological features of tissue-engineered 
cartilage after implantation in an 8-week in vivo study. Three types of scaffolds, 
including silk, collagen, and gelatin seeded by hMSCs and treated with chondrogenic 
media, were cultured for three weeks. As the second phase, the constructs are implanted 
subcutaneously into an ectopic animal model. The mice are under study for 8 weeks and 
imaged at four time points. MRE and MRI derived parameters, including the MR 
transverse relaxation time T2 and the shear stiffness (μ), are measured during the study. 
At the conclusion of the study, expressions of cartilage-specific genes are quantitated 
using real-time RT-PCR. The results of this study will provide researchers with a 
noninvasive rapid-feedback method for improving the engineered outcome. The 
developed method allows sacrificing less of animals needed per experiment. In a 
longitudinal experiment each animal is studied as its own control, thereby enabling 
repeated evaluation of cartilage features, and more measures statistics. This research will 
enable the design of better tissue-engineered cartilage that can be translated into 
treatment of tissue defects. 
87 
 
  
 
 
6.2 Experimental 
6.2.1 Cell culture and preparation of different tissue engineering cartilage 
constructs  
Healthy human bone MSCs isolated from fresh marrow cells were provided 
commercially (Lonza, Walkersville, MD). Cells were cultured in a basic culture medium 
composed of Dulbecco’s Modified Eagle’s Medium (Gibco, Carlsbad, CA) supplemented 
with 10% fetal bovine serum (Gibco, Carlsbad, CA) and 1% antibiotics/antimycotics 
(Invitrogen, Carlsbad, CA. The chondrogenesis culture medium was created by adding 10 
nM dexamethasone, 40 μg/ml L-proline, 50 μg/ml ascorbic acid-2-phosphate (Sigma, St. 
Louis, MO), 10 ng/ml TGF-β3 (Peprotech,Rocky Hill, NJ) and ITSTM premix 
(containing 6.25 μg/ml insulin, 6.25μg /ml transferrin, 5.33μg/ml linoleic acid, and 1.25 
mg/ml bovine serum albumin) (BD Biosciences, Bedford, MA) to the basic culture 
medium [265, 266]. 
The engineering outcome will depend on the scaffold material and physical 
properties, including the pore size and the scaffold composition [267]. Three different 
scaffolds were selected for cartilage TE: gelatin sponges with a pore size of 250 microns 
(Pharmacia & Upjohn, Kalamazoo, MI), fabricated protein silk with a pore size of 500 
microns (Department of Biomedical Engineering, Tufts University, Medford, MA), and 
collagen constructs with a pore size of 350 microns (Kensey Nash, Exton, PA). 
Constructs were biopsy punched to a 5 mm diameter. Gelatin and collagen constructs 
were seeded, in 50 μl DMEM medium, at 0.5 × 106 cells/scaffold with the assistance of a 
vacuum using a 20 ml syringe [268, 269]. They then were moved to 24-well plates after 
two hours. For silk scaffolds, the protocol presented by Rockwood et al. [270] was 
adopted. Briefly, silk scaffolds were placed in 24-well plates, and their pores evacuated 
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with a Pasteur pipette; then, they were seeded at 0.5 × 10
6
 cells/scaffold, which were 
delivered in equal portions to the top and bottom surfaces. After 15 minutes in the 
incubator, scaffolds were rotated 180°, and 10 μl of cell free medium was added to 
maintain hydration. This process was repeated four times. The constructs were cultured 
for 3 weeks before implantation. 
6.2.2 In vivo construct implantation  
The proposed animal work is approved by the Animal Care Committee at the 
University of Nebraska-Lincoln (UNL). Currently, we have an approval from IACUC for 
the implantation of MSC-derived engineered tissues in mice. Constructs were implanted 
subcutaneously in eight-week-old male nude immunodeficient mice (nu/nuJ, Jackson 
Laboratories, Bar Harbor, ME). For the implantation surgery, the mice were anesthetized 
with 5 percent isoflurane. The surgical site was disinfected with betadine and isopropyl 
alcohol. A 25 mm incision was made mid-sagittal across the dorsum in the prescapular 
region, where a subcutaneous pocket was created on back of the midline. The constructs 
were implanted and fixed in location by placing a suture through the muscle. The animals 
were allowed to heal for two weeks before removing the suture and conducting 
MRE/MRI measurements. The mice were examined for up to eight weeks following 
implantation. 
6.2.3 MRI system and measurement of MR parameters 
All MRI acquisitions were conducted at 9.4 T (400 MHz for protons) using an 89-
mm vertical bore magnet equipped with triple axis gradients (maximum strength 100 
G/cm) (Agilent, Santa Clara, CA). Measurements were acquired using a 4-cm Millipede 
RF imaging probe to transmit and receive the nuclear magnetic resonance signals. T2-
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weighted images were acquired from sagittal sections for the silk construct, axial sections 
for the collagen construct, and coronal sections for the gelatin construct using a spin echo 
multi-slice (SEMS) sequence with the following parameters: repetition time (TR) / echo 
time (TE) = 1000/13.82 ms, average = 2, matrix = 128×128 pixels, field-of-view (FOV) = 
14-20 mm
2
, slice thickness = 1 mm. Transverse relaxation times T2 were measured by 
applying multiple-echo spin echo imaging sequences to acquire 32 echoes (TR, 4000 ms; 
TE, 10 ms; number of echoes NE, 32; average, 2; FOV, 14-20 mm
2
; matrix, 128×128 
pixels; slice thickness, 1 mm). T2 values were extracted from the experimental data using 
a least-squares single exponential fitting, and a low-pass filter was applied to improve the 
readability of the maps 
6.2.4 Magnetic resonance elastography 
A modified phase contrast pulse sequence integrated with the imaging software, 
VnmrJ 3.1, was used to acquire MRE data. The MRE interface allows the user to select 
the MRE parameters, including gradient amplitude (0-100 G/cm), actuator frequency, 
delay between the mechanical actuator and the bipolar gradient, MEG direction, and 
number of bipolar pairs. The design and setup of the MRE system have already been 
demonstrated by Othman et al. [257]. An actuator was designed to provide sufficient 
displacement into the cartilage construct as shown in Figure 6-1a. The design was 
achieved through the use of a piezoelectric bending motor (Piezo System, Woburn, MA) 
secured to a curvature around the mouse. A plastic cap attached to the other side of the 
piezoelectric motor was coupled to the mouse’s body adjacent to the tissue construct. The 
actuator was driven by a signal generator (Tektronix, Beaverton, OR) followed by an 
amplifier (Piezo System, Woburn, MA). Before placement in the scanner, the actuator 
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was characterized using a Laser Doppler Vibrometer and its resonance frequency 
providing the largest vibration is identified as represented in Figure 6-1b. The mice were 
placed in ventral recumbency onto an especial-designed animal holder and were 
maintained anesthetized with 1.5-2% isoflurane (Molecular Imaging Products Company, 
Bend, OR) and monitored (Small Animal Instruments, inc., Stony Brook, NY). MRE 
acquisitions were carried out with the addition of external respiration gating to reduce 
motion artifacts. 
 
Figure 6-1 (a) Experimental setup of in vivo MRE. The actuator was designed to be 
placed adjacent to the tissue for maximum wave propagation into the construct. The 
arched suspension design permitted the actuator to be rotated over the curvature of 
the mouse’s body to optimize positioning. The current device is adapted for the 
operation of 400 - 1600 Hz piezoelectric actuators. (b) Actuator characterization. 
The frequency response of the actuator will be determined by sending a white noise 
to the system, and performing Fourier Transform. A continuous sinusoid signal at 
the resonance frequency will be delivered to the sample to determine the actuation 
maximum amplitude. 
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MRE scans were conducted using a spin-echo based phase contrast sequence with 
TR=1000 ms, TE=19-21 ms, acquisition matrix=128×128, FOV=14-20 mm
2,
 mechanical 
frequency f=750-800 Hz, N=2 (number of gradient bipolar pulses), and maximum 
MEG=95 G/cm. MRE acquisitions were carried out with six phase-offsets (between 
mechanical waveform and MEG) equally spaced across each vibration cycle. Resultant 
six wave images were processed using a MATLAB code based on a previously 
developed spatiotemporal filtering approach to solve the inverse problem and calculate 
the shear stiffness of the constructs [86, 252, 271, 272]. 
6.2.5 RNA extraction and cDNA synthesis 
Fresh constructs were transferred into 1.5 ml centrifuge tubes. Samples were 
homogenized in 1.5 ml Trizol (Life technologies,Grand Island, NY) using mortar plus 
liquid nitrogen, and RNA was extracted according to the single-step acid-phenol-
guanidinium method [273]. The RNA samples were reverse transcribed into cDNA using 
a QuantiTect Reverse Transcription Kit according to the manufacturer’s protocol 
(Qiagen, Hilden, Germany). A 300 ng total RNA sample was used for the single strand 
cDNA synthesis. The reverse transcription reaction was incubated at 42 °C for 30 min, 
and terminated at 95 °C for 3 min. 
6.2.6 Real time reverse transcription-polymerase chain reaction (real-time RT-PCR)  
Agg and Collagen II transcript levels were quantified using Fast SYBR® Green 
Master Mix (Life Technologies,Grand Island, NY) and the ABI Prism 7000 real time 
PCR system (Applied Biosystems, Barlsbad, CA). The transcript data were normalized to 
the housekeeping gene, glyceraldehydes-3-phosphate-dehydrogenase (GAPDH). 
Reactions were performed in triplicate. Expression of target genes was normalized to 
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GAPDH and expressed as the fold ratio relative to the control group, using the 2
-ΔΔCT
 
method [274]. Specific genes and primer sequences are listed in Table 6-1. 
Table 6-1 Amplified genes, and specific primer. 
Gene Primer Sequence  
Agg 
 
Collagen II 
F: 5’-AGGCAGCGTGATCCTTACC-3’ 
R: 5’-GGCCTCTCCAGTCTCATTCTCTC-3’ 
F: 5’-CGTCCAGATGACCTTCCTACG-3’ 
R: 5’-TGAGCAGGGCCTTCTTGAG-3’ 
F: 5’-TCCACTGGCGTCTTCACC-3’ 
R: 5’-GGCAGAGATGATGACCCTTT-3’ 
GAPDH 
 
6.2.7 Statistical analysis  
All data are expressed as means ± standard deviations. Statistical analysis was 
performed by one-way analysis of variance (ANOVA) in conjunction with Tukey’s post 
hoc comparisons for multiple comparisons with p values less than 0.05 considered 
significant. 
6.3 Results 
The in vivo results indicate variations of imaging markers during growth and 
differentiation of the chondrogenic constructs toward cartilage. Figure 6-2 demonstrates 
magnitude MRI images, T2 relaxation maps, displacement fields, and stiffness maps 
generated for the silk scaffold at different time points (week 2, week 3, week 4, and week 
8 after implantation). Average of T2 relaxation times calculated inside the region-of-
interests (ROIs) changed from 91.2 ± 7.6 ms at week 2 after implantation to 71.6 ± 6.1 
ms at week 4 and 67.6 ± 3.1 ms at week 8. Average stiffness values increased from 7.6 ± 
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2.0 kPa at week 2 after implantation to 13.7 ± 4.3 kPa at week 4 and 17.2 ± 3.1 at week 8. 
Measured values for the collagen construct are presented in Figure 6-3. Average T2 times 
decreased from 75.2 ± 18.4 ms to 61.3 ± 7.1 ms at week 4 and 58.4 ± 4.2 ms at week 8. 
Average stiffness values for the collagen constructs increased from 4.6 ± 1.7 kPa to 12.0 
± 3.7 kPa at week 4 and to 14.7 ± 3.8 kPa at week 8. 
 
Figure 6-2 Silk construct development map over an 8-week in vivo study at four time 
points. Shown from left to right are the magnitude SEMS images, T2 relaxation 
maps, displacement fields, and stiffness maps of the construct. Average of T2 
relaxation times calculated inside the ROIs reduced from 91.2 ± 7.6 ms at week 2 
after implantation to 71.6 ± 6.1 ms at week 4 and 67.9 ± 3.1 at week 8. Average 
stiffness values increased from 7.6 ± 2.0 kPa at week 2 after implantation to 13.7 ± 
4.3 kPa at week 4 and 17.2 ± 3.1 at week 8. 
Figure 6-4a demonstrates a comparison of transverse MR relaxation times 
measured for the three implanted constructs (silk, collagen, and gelatin). At week 2, T2 
94 
 
  
 
 
times measured for the silk, collagen, and gelatin constructs were 91.2 ± 7.6 ms, 87.4 ± 
9.2 ms, and 75.2 ± 10.3 ms respectively. At the end of the study T2 decreased to 67.9 ± 
3.1 ms for the silk, 61.1 ± 3.8 ms for the gelatin, and 58.4 ± 4.2 ms for the collagen 
constructs. Our data showed that T2 times dropped 25% for the silk, 30% for the gelatin, 
and 22% for the collagen in the course of the study.  
 
Figure 6-3 Collagen construct development map over an 8-week in vivo study at four 
time points. Shown from left to right are the magnitude SEMS image, T2 relaxation 
map, and stiffness map of the constructs. Average T2 relaxation times decreased 
from 75.2 ±- 18.4 ms at week 2 after implantation to 61.3 ± 7.1 at week 4 ms and 58.4 
± 4.2 at week 8. Average stiffness values increased from 4.6 ± 1.7 kPa at week 2 after 
implantation to 12.0 ± 3.7 kPa at week 4 and to 14.7 ± 3.8 kPa at week 8. 
Shear stiffness data for all three constructs are illustrated in Figure 6-4b. The gelatin 
construct showed the most shear stiffness increase from 6.4 ± 1.0 kPa to 22.6 ± 4.1 kPa. 
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Shear stiffness of the collagen construct increased moderately from 4.6 ± 1.7 kPa to 14.7 
± 3.8 kPa from week 2 to week 8. Shear stiffness of the silk construct increased less than 
the others from 7.6 ± 2.0 kPa to 17.2 ± 3.1 kPa. 
 
 
(a) (b) 
Figure 6-4 Characterization of T2 relaxation time and shear stiffness as imaging 
markers for three hMSC seeded cartilage constructs (silk, gelatin, and collagen). (a) 
Comparison of the T2 relaxation alterations among the cartilage constructs. (b) 
Comparison of shear stiffness changes among the three cartilage constructs. 
Transcript levels of cartilage-related ECM genes were assessed using RT-PCR to 
determine chondrogenic differentiation after 3 weeks of in vitro culture and 8 weeks of in 
vivo implantation of MSCs seeded on silk, collagen, and gelatin scaffolds. Levels of Agg 
and Collagen II, cartilage-related ECM genes, were analyzed and normalized to GAPDH 
within the linear range of amplification. As shown in Figure 6-5, transcript levels of Agg 
and Collagen II in cells within the gelatin (a) and collagen (b) constructs of in vivo 
implantation were significantly upregulated in comparison to in vitro culture and the 
control (P<0.001). The transcript levels of Collagen II in cells within the silk (c) 
constructs of in vivo implantation were significantly upregulated in comparison to in vitro 
culture and the control (P<0.001). The transcript levels of Agg in cells within the silk (c) 
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constructs of in vivo implantation were upregulated in comparison to in vitro culture and 
the control (P=0.076). 
 
Figure 6-5 Transcript levels measured by RT-PCR for Aggrecan (Agg) and 
Collagen type II (Collagen II) of cartilage-relate ECM genes in vitro and in vivo 
within the gelatin (a), collagen (b) and silk (c) construct. Data are shown relative to 
the expression of the respective transcript by undifferentiated MSCs at week 3 and 
represented as the average ± standard deviation (***P<0.001). 
6.4 Discussion 
In this study, longitudinal evaluation of hMSCs-derived cartilage constructs, 
seeded into three types of scaffolds (silk, collagen, and gelatin) and implanted 
subcutaneously in mice, were performed by measuring transverse MR relaxation time T2 
and shear stiffness. We have explored the potential of stiffness mapping as well as T2 
mapping at 9.4 T in characterizing cartilage growth, a “tissue engineering” approach, 
after implantations. Expression of Agg and type II Collagen genes was measured by 
gene-specific quantitative competitive reverse transcriptase-polymerase chain reactions. 
The in vitro culture is very important before implantation on the engineered 
articular cartilage properties and alleviation of post-implantation inflammation in 
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different animal models [275-277]. The current study cultured the tissue-engineered 
cartilage within silk, collagen and gelatin scaffolds over 3 weeks. The expression of 
cartilage related ECM genes were analyzed by RT-PCR. The current results confirmed 
the expression of Collagen II and Agg were upregulated within silk, collagen, and gelatin 
scaffold after 3 weeks in vitro culture, compared with control (Figure 6-5).  
In cartilage tissue engineering several factors must be investigated after 
implantation, such as localization, depth, and diameter of the constructs, the type of 
scaffolds, cells, and growth factors. To date, macroscopic and histological studies remain 
the “gold standard” to characterize the type and the quality of the repair tissue at different 
time points, but are invasive in nature. For example arthroscopy, while promising, limits 
the number of longitudinal explorations in clinical practice. Therefore, the development 
of noninvasive techniques seems necessary for the future to evaluate longitudinally the 
different tissue engineering techniques used for cartilage repair. Numerous studies have 
been performed to study effective imaging markers in tissue repair in various 
experimental models of cartilage defects in human [278-280] or animal [281, 282]. 
Chou1 et al. in a study temporally characterized the magnetic resonance relaxation time 
of a tri-copolymer sponge in vivo in a rodent heterotopic model. They described that the 
transverse MR relaxation time (T2) of the sponge decreased significantly over time while 
longitudinal relaxation time T1 remained stable, compared with the control [283]. Ballyns 
et al. used MRI and CT to design custom-printed molds that enabled the generation of 
anatomically shaped cartilage constructs [284]. To our knowledge, previous studies of 
cartilage growth characterization using both T2 values and shear stiffness have not been 
performed. 
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In the current research, we noted in all three types of implanted cartilage 
constructs a progressive and significant decrease of T2 over the 8-week study. Average 
transverse MR relaxation time decreased 25% for the silk, 30% for the gelatin, and 23% 
for the collagen based constructs. Total differentiated tissue was characterized by the 
smallest average T2 value comparing to the onset of the study. This reduction can be 
because of a decrease in the relative water content and an increase of T2-shortening 
effects in the constructs. We also observed stiffening of the tissue constructs along with 
the differentiation and growth of the cells. MRE measurements revealed that the shear 
stiffness increased nearly two-fold for the silk, three-fold for the collagen, and three-and-
a-half-fold for the gelatin based cartilage constructs. This increase in shear stiffness of the 
constructs can be due to formation of their net-like organized structure of the collagen 
type I and II fibers and increasing concentration of proteoglycans (PGs) [285]. In 
agreement with previous reports [286-288], the current results demonstrated that the 
expression of Collagen II and Agg were upregulated within silk, collagen, and gelatin 
scaffold after 8 weeks implantation, compared with in vitro culture (Figure 6-5).   
Cartilage is affected in vivo and in vitro by several biomechanical forces like 
direct compression, tensile and shear forces, or the generation of hydrostatic pressure and 
electric gradients, as well as changes in the pH [285]. The dynamic processes that occur 
in cartilage are necessary to maintain its structure and function and have to be applied in 
the tissue engineering of cartilage as well. These effects and their correlation with 
imaging biomarkers can be investigated in future studies. 
The results of this research demonstrated that MRI provides the basis for 
morphological evaluation of engineered cartilage tissues, whereas biochemical MRI 
99 
 
  
 
 
(measuring transverse MR relaxation) provides deeper insight into the composition of the 
tissue. Besides, MRE allows observing changes in mechanical properties of the 
engineered tissue. The imaging markers achieved in this study through noninvasive 
biomedical imaging techniques can improve cartilage repair and also can be used for the 
diagnosis of surrounding pathologies within defect sites. The method introduced in the 
present study can effectively reduce the number of animals needed for statistical 
significance in any further in vivo study without compromising reliability. A combination 
of all of these together may, in the future, represent a desirable multimodal approach to 
follow-up after cartilage repair procedures. 
 
 
  
100 
 
  
 
 
CHAPTER 7 
 
ASSESSMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING MRE AND qPCR 
 
7.1 Introduction 
Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic hepatic 
disorder among cases with acute obesity [289]. It can progress from primitive steatosis to 
steatohepatitis and cirrhosis in patients without significant alcohol use [80, 290]. NAFLD 
is one of the diseases in vogue worldwide, especially in developed countries, with a 
prevalence of 30% in adults and 13% in children [290-292]. A wide range of liver 
diseases can be included in the NAFLD spectrum such as fatty liver or steatosis 
(agglomeration of fat in hepatocytes), nonalcoholic steatohepatitis, NASH (inflammation 
in liver due to fat) and cirrhosis (progressive and irreversible stage of fatty liver disease 
leading to scarring in liver) [293]. In 2011, United Network for Organ Sharing registry 
database for liver transplant recipients reported that NASH, the progressive form of 
NAFLD, is the fourth most leading cause of liver transplant surgery [294]. Sedentary life 
style, fast-food consumption, and the tendency of people to consume high-fat and high-
fructose corn syrup content food are significant factors which increase the number of 
NAFLD in developed countries [295]. Studies showed that the mean body mass index 
(BMI) and type 2 diabetes are important factors that increase the risk of NAFLD [296, 
297]. 
Pathogenesis of NAFLD is defined as agglomeration of fat inside hepatocytes 
leading to a metabolic disorder identified with central obesity and insulin resistance [291, 
293]. Histologically, existence of steatosis of more than 5% is an evidence for NAFLD. 
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In the progressive stage, steatosis advances to steatohepatitis, which is signaled by the 
presence of steatosis inflammation and hepatocellular injury [294]. The frequent causes 
of NAFLD are central adiposity, obesity, insulin resistance, metabolic syndrome and type 
II diabetes [289]. Figure 7-1 demonstrates the relationships between different types of 
NAFLD [78, 298] .  
 
Figure 7-1 Interactions of different factors in pathogenesis of NAFLD. Life style, 
genetic defects, diabetes, and hepatic C virus can result in insulin resistance which is 
an important factor in developing NAFLD. 
Among them, insulin resistance was shown to play a significant role in NAFLD [299]. 
Several biomarkers of insulin resistance have been investigated in previous studies such 
as interleukin (IL)-6, tumor necrosis factor a (Tnfa), and leptin [300], insulin-like growth 
factor-1 (Igf1) [62], aka Glut4 (insulin resistance is suppressed by increase of aka Glut4 
expression) [301], and various antioxidant defense markers such as Sod1 and Sod2 
(relative gene expression decreases following NAFLD) [302]. aka Tnfa plays a 
significant role in insulin resistance by damaging insulin signaling; therefore, an 
increased level of Tnfa in hepatocytes is an exacerbating factor in fatty liver disease 
[298]. Other studies showed that nonalcoholic steatohepatitis is relevant to increased 
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microsomal cytochrome P450 2E1 (CYP2E1) expression in liver cells by changing the 
activity of mitogen-activated proteins [303]. The mRNA level changes of these genes in 
NAFLD can be disruptive for cell proliferation, differentiation, apoptosis, or migration; 
thus, quantification of their abundance and assessment of their correlation with shear 
stiffness in NAFLD may be advantageous in the diagnosis and treatment stages. In 
current research, real-time Polymerase Chain Reaction (PCR) is utilized to quantify and 
monitor gene expression changes in the liver [304]. 
Imaging modalities such as ultrasound, computed tomography (CT), and magnetic 
resonance imaging (MRI) are commonly employed in the diagnosis of NAFLD [305]. 
While imaging techniques are merely suggestive, the histological features of biopsy 
samples taken from fatty liver are considered as a gold standard for determining the 
severity of the disease [306, 307]. However, it was reported that liver tissue histology in 
patients who have suffered from NAFLD in the cirrhosis stage do not necessarily show 
enough features for this form of assessment [294]. Furthermore, promising assessment of 
NAFLD is achieved by taking several biopsy samples at different time points for 
monitoring the progression of NAFLD [296, 308]. For instance, Charlton et al. reported 
that a number of biopsies in a year rather than yearly biopsies are necessary to detect the 
high rate of steatosis [309]. Therefore, an analysis of more biopsy samples over time may 
be required to monitor the degree of fatty liver disease which is unpleasant for patients 
[294].  
Knowing that MR imaging, the dominant soft-tissue imaging technique, is not 
able to reliably assess the intermediate stages of fibrosis [310], magnetic resonance 
elastography (MRE) has emerged to noninvasively measure the liver’s stiffness. MRE 
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can correlate the presence of liver fibrosis in patients with chronic liver disease [254]. 
First described by Muthupillai et al. in 1995, MRE is a phase-contrast based MRI 
technique that uses propagating shear waves through tissue to noninvasively characterize 
mechanical properties of materials such as the shear modulus (μ)or Young’s modulus 
[76]. Historically, physicians have been using palpation to discover unusual changes in 
mechanical properties of tissues, which can be a sign of abnormalities such as cancers 
and tumors; however, diagnosis through palpation is constrained to the approachable 
areas of the body. On the other hand, CT, MRI, and ultrasound frequently fail to detect 
stiffness alterations of tissues in a number of pathological conditions, for example, in 
fibrotic liver diseases which are detectable by MRE [77-79]. Besides magnetic resonance 
elastography, ultrasound based elastography (UE), introduced by Ophir et al. in 1991, is 
another noninvasive method for imaging the elasticity of biological tissues. Although UE 
is a successful method and is clinically used, it is limited by the signal to noise ratio 
(SNR) and low resolution [76, 80, 81]. Recently, MRE has been demonstrated in clinical 
studies as a diagnostic method for abnormalities in breast, liver, kidney, prostate, brain, 
blood vessels, heart, and skeletal muscle. Additionally, MRE was approved clinically by 
the food and drug administration (FDA) for assessment of chronic liver diseases [8-11].  
The objective of this feasibility study was to evaluate the correlation of liver 
stiffness alterations with changes of fibrosis-specific genes expression for assessment of 
NAFLD. Microscopic MRE, described by Othman et al. in 2005 [82, 86, 311] as a 
method of high spatial-resolution MRE, was used to quantify mechanical properties of 
the liver tissue. Difference in liver tissue stiffness between normal mice and subjects 
104 
 
  
 
 
suffering from NAFLD was measured. Real-time PCR was performed on the genes 
playing an important role in NAFLD to quantitate their mRNA abundance. 
7.2 Experimental  
7.2.1 Animal Handling 
All animal experiments approved by UNL’s Institutional Animal Care and Use 
Committees (IACUC).Eleven C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) 7-
week old weighing 23-25 g were randomly grouped into control (n=5) and pathologic 
(n=6) populations. The pathologic population was allowed to consume an unlimited 
amount of a high fat diet (TD.06415 adjusted calorie diet [45/Fat]) during a four week 
study while the control group was fed a regular rodent diet (2016 Teklad Global 16% 
Protein). Animals were kept in metabolic cages under ordinary day-night cycles of light, 
temperature, and pressure. Mice acclimated to the environment for a week before starting 
the experiments. The normal group and the diseased group were imaged once a week in 
the course of the exposure period. Before imaging, the mice were placed inside a closed 
chamber and induced by 2% isoflurane, an inhalation anesthetic, using an anesthesia gas 
veterinary evaporator (Molecular Imaging Products Company, Bend, OR). Then, they 
were positioned in ventral recumbency onto an animal holder, shown in Figure 7-2, in 
such a way that their snouts were inside a nose cone connected to the anesthesia 
evaporator, thus allowing inhalation of anesthesia during the experiment (Figure 7-2). 
The anesthesia was kept at 0.5-2% isoflurane in O2 with a flow rate of 2 ml/min 
throughout the imaging study. The animal’s respiration, heart rate, and body temperature 
were monitored throughout imaging by an MR-compatible small animals monitoring and 
gating system (Small Animal Instruments, inc., Stony Brook, NY) [312]. This system is 
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designed for small rodent imaging and can be linked to an MRI scanner for gating. A 
rectal thermistor temperature probe covered with lubricant was mounted and its lead was 
taped to the mouse’s tail. The animal’s respiration rate was measured by a pneumatic 
sensor placed near the abdomen and secured with tape. Heart rate was monitored using a 
mouse tail/ankle fiber optic oximetry sensor attached to animal’s left ankle. A loop of 
thread was placed around the foot of the mouse and taped to maintain the ankle in the 
sensor. An air heater was utilized to regulate the animal’s body temperature inside the 
magnet bore. 
7.2.2 MRE Setup 
All MRE experiments were performed at 9.4T (400 MHz for protons) utilizing an 
89 mm vertical bore MR scanner (Agilent, Santa Clara, CA). MRE acquisitions were 
acquired using a 40 mm Millipede RF imaging probe with triple axis gradients 
(maximum strength 100 G/cm).  
 
Figure 7-2 Schematic diagram of in vivo experimental setup for MRE assessment of 
liver tissue. A piezoelectric actuator is coupled with the skin of the animal above the 
liver and inclined to right lateral side of body. The specially designed cap transfers 
545 Hz transversal vibration to liver tissue by oscillating the right lateral side of the 
animal body. The resulting traveling shear waves propagate through liver tissue 
from the posterior to the anterior. 
 
Motion Direction 
Direction  
Piezoelectric Bending Driver 
Function 
Generator 
Amplifier MRI 
Console 
Triggering Pulse 
Nose Cone 
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Propagating shear waves were generated through transverse motion of an 
especially designed actuator shown in Figure 7-2. The actuator consisted of a bending 
piezoelectric motor (Piezo systems, inc., Woburn, MA) attached to a plastic cap designed 
to transfer the motion to the animal. It was secured to a curvature around the animal and, 
by coupling it to the right lateral side of the animal above the liver, motion was 
transferred to the liver tissue. The actuator was driven using an amplified sinusoidal 
signal generated by a function generator (Tektronix, Beaverton, OR) and triggered by the 
MRE imaging sequence through a triggering pulse from the MR scanner console. The 
transverse motion generated shear waves propagating through liver tissue in a posterior to 
anterior pathway. Prior to imaging, actuator characterization was carried out utilizing a 
Laser Doppler Vibrometer (Polytec, Dexter, MI) to generate maximum tissue 
displacement, approximately 50-150 µm. A laser beam was pointed onto the surface of 
the plastic cap attached to the piezoelectric bending motor. The reflected beam was 
applied by the vibrometer to measure actuator’s velocity and displacement. The 
displacement amplitudes of the actuator were in the order of 200-400 µm. Typical 
velocity and displacement signals of the actuator are shown in Figure 7-3.  
 
Figure 7-3 Characterization of the actuator using a Laser Doppler Vibrometer. 
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Studies showed that at least a half wavelength traveling through a tissue is 
necessary to calculate its mechanical properties [313]. On the other hand, using higher 
frequencies leads to more attenuation and less wave propagation within the tissue. To 
reduce these effects on our measurements, frequencies ranging from 500 to 600 Hz were 
used in this study, which were determined through preliminary experiments. 
MRE acquisitions were conducted using a gradient-echo based phase contrast 
sequence with repetition time TR of 300 ms, echo time TE of 4-5 ms, flip angle of 25º, 
acquisition matrix of 128×128, axial field-of-view FOV of 24 to 28 mm
2
, average=2 and 
slice thickness of 1 mm. The applied mechanical vibration was generated by a sinusoidal 
signal with Vpp (peak-to-peak voltage) of 200 V and the resonance frequency of the 
actuator. The number of gradient pulses and maximum of motion-encoding gradient were 
selected to be one and 80-90 G/cm respectively. The motion-encoding gradient pairs are 
incorporated along the same direction as the shear waves, at the same frequency of 
mechanical excitation, and phase-locked to it. To compensate respiratory and cardiac 
motion, MR acquisitions were gated using respiration and pulse oximetry trigger signals. 
The total acquisition time was approximately 7:40 min. To calculate the local 
displacement and shear moduli maps (elastograms), imaging was repeated in six phase 
offsets equally distributed over one cycle of the mechanical excitations. Six offsets were 
used instead of eight offsets to shorten the in vivo imaging time. The acquisitions were 
performed twice, toggling the polarity of gradients for phase image subtraction and 
generating wave images. The intensity of each pixel on wave images indicates 
displacement amplitude at that point in the direction of applied motion-encoding 
gradients. To avoid wrapping artifact we tried to adjust the maximum of motion-encoding 
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gradient or the amplitude of displacement within the tissue; however, in some cases, 
because of necessity of applying stronger displacements near actuator to achieve 
sufficient penetration depth, phase-wrapping was unavoidable; these cases were phase 
unwrapped by applying a two-dimensional Fourier Transform algorithm [314].  
The mass density of tissue-like materials is close to that of water (1000- 1100 
kg/m
3
); therefore, the shear modulus at f=545 Hz, at which most of experiments were 
done, and ρ=1050 kg/m3 can be simplified to                . The wavelength of 
traveling shear waves can be determined by measuring the peak-to-peak distance of the 
wave train in the direction it is propagating. In this study, a MATLAB code written based 
on a previously developed spatiotemporal filtering approach was utilized to solve the 
inverse problem and calculate the local mechanical properties of the liver tissue from the 
measured wave images [85-87, 315]. The complex pattern of traveling shear waves in 
anisotropic and heterogeneous material can be handled using multi-directional filtering 
[86]. In the applied algorithm, each wave field was filtered in 8 different angles 
(multiples of 45º) and the weighted data from all directions were combined to reconstruct 
the local mechanical properties [86, 297]. A region-of-interest (ROI) surrounding the 
liver tissue was selected from the magnitude image. Any regions of ROI that didn’t have 
enough shear wave amplitude (due to insufficient MR signal or weak penetration) were 
excluded. Means and standard deviations (SD) of stiffness values were calculated over 
the ROI for all mice in each study group. Eventually, the mean and SD of each study 
group were determined in order to find the cross-subject alteration. SD of each study 
group were calculated using the following equation  
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 (7.1) 
where nj represents the number of pixels in each ROI, Mj and SDj are ROI mean and 
standard deviation respectively, and M is the mean of all subjects. 
7.2.3 Body Scan and Real-time PCR 
At the conclusion of the four week study, the animals were euthanized and the 
tissues were excised for the body scan. The densities of fat in the liver tissues were 
measured using the Lunar PIXImus dual-energy x-ray absorptiometry (GE Medical 
Systems-Lunar, Madison, WI). To quantify the mouse fibrosis-related genes, adipose, 
muscle, and liver tissues were isolated and RNAs were collected for the qPCR analyses 
using the 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). 
Forward and reverse primers were designed and synthesized for the mouse Tnfa, 
Lep, Igf1, Slc2a4 (aka Glut4), Sod1 and Sod2 genes, as given in Table 7-1. Each set of 
primers was tested empirically to determine the maximal concentration that produced 
specific amplification of the target sequence. qPCR reactions were carried out using 
equivalent dilutions of each cDNA sample, Power SYBR Green PCR Master Mix 
(Applied Biosystems), and the empirically determined concentration of each primer as 
previously described [316]. The relative abundance of each specific gene product was 
divided by the relative abundance of β-actin in each sample to generate a normalized 
abundance for each gene interrogated. The resulting normalized data for each candidate 
mRNA was then compared to the mean normalized mRNA abundance in mice fed with a 
normal rodent chow. 
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Table 7-1 qPCR primer sequences for mouse Tnfa, Lep, Igf1, Slc2a4 (aka Glut4), 
Sod1 and Sod2. 
 
7.2.4 Statistical Analysis 
The statistical analyses for MRE and qPCR data were performed using GraphPad 
Prism 5.0 (GraphPad Software, La Jolla, CA). A paired student t-test was performed to 
determine the significance of the liver stiffness variations as well as gene expression 
alterations between normal and diseased populations.  
7.3 Results 
During the study, the body mass of animals increased from 24 ± 1 g to 27 ± 1 g in 
both healthy and diseased groups. Figure 7-4 shows axial magnitude image from the liver 
tissue of a typical healthy mouse and corresponding filtered shear wave image and 
stiffness map. The shear wave image and shear stiffness map were generated inside a 
ROI drawn to cover the largest region of the liver tissue possible to avoid the vascular 
system. i.e., Axial MRI images of the liver tissues include transverse cross section of the 
liver vasculature, which should be eliminated from ROIs selected for post-processing. 
MRI magnitude and phase images were segmented through different available options, 
including threshold, Fuzzy C- means [317], and manual. The average estimated shear 
stiffness for the healthy liver tissue was about 4.7 ± 0.7 kPa acquired at 545 Hz. The 
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imaging was repeated weekly (five times) during the study. Figure 7-5 illustrates 
magnitude images, filtered shear wave images, and stiffness maps of the liver tissue 
acquired for a mouse belonging to the diseased group at five time points. After three 
weeks of study, the shear stiffness map demonstrated areas of higher shear modulus.  
 
Figure 7-4 Demonstration of an axial magnitude image from the liver tissue of a 
typical healthy mouse and corresponding filtered shear wave image and stiffness 
map. The liver tissue is highlighted by a dashed line. A region of interest highlighted 
by a white line chosen to include the liver tissue and avoid vasculature system of the 
liver (Vasculature system should be excluded from calculations). The place of the 
actuator and the direction of vibrations are denoted by a white dotted arrow. 
Table 7-2 lists means and SDs of stiffness, storage and loss modulus measured for 
healthy and diseased populations during the study. A comparison of shear stiffness 
between these two populations is represented in Figure 7-6. The liver stiffness increased 
within the fatty liver tissue. No region of such high stiffness has been measured in 
corresponding control animals. The mean stiffness in fatty diet group changed from 4.3 ± 
0.7 kPa to 7.2  ± 1.0 kPa  (P<0.02) after four weeks of feeding with high fat diet. 
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Figure 7-5 Magnitude 
images, filtered shear 
wave, and stiffness 
estimations of a mouse 
liver at five different 
time points. Imaging was 
carried out using a 
gradient echo based 
imaging sequence with 
the following 
parameters: TR = 300 
ms, TE = 4-5 ms, FOV = 
24-28 mm, slice 
thickness = 1 mm, 
matrix = 128 x 128 
pixels, NEX = 2, 
operating frequency = 
545, number of bipolar 
pairs = 1, and gradient 
amplitude = 80-90 G/cm. 
An increase in stiffness 
can be seen in the liver 
tissue at the end of the 
study, while values in the 
healthy subjects change 
insignificantly. The place 
of the mechanical 
actuator coupled to the 
animal’s body is 
illustrated by a dotted 
line in all magnitude 
images. The arrows 
show the direction of 
vibration. 
After four weeks, body composition data showed a slight difference from 19.54 ± 
1.65 to 17.28 ±  0.64 in body fat percent between mice fed a high fat versus control diet 
respectively (P<0.3). Figure 7-7 shows the alterations in mRNA abundance of Slc2a4 
(aka Glut4), Igf1, Sod1 and Sod2 in the liver and muscle of high fat group compared to 
the control. Liver glut4 mRNA abundance was increased nearly 4-fold (P < 0.6) in liver 
tissue while in the muscle tissue didn’t change significantly. Furthermore, leptin mRNA 
 
Magnitude Image   Filtered Waves (μm)   Stiffness (kPa) 
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abundance was elevated approximately 2-fold (P < 0.1) in adipose tissue whilst Tnfα 
decreased %10 in high fat diet group. 
Table 7-2 The means and standard deviations of measured stiffness, storage 
modulus, and loss modulus at five time points during the study for both normal and 
high fat diet groups. 
 
 
 
Figure 7-6 Mean and SD values of the liver stiffness for high fat group versus 
control (P<0.02). 
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Figure 7-7 mRNA abundance for fibrosis-related genes measured for the liver tissue 
and muscle. (ND: Normal Diet, NFD: High Fat Diet). 
7.4 Discussion 
This research is the first to compare MRE liver stiffness and fibrosis-related gene 
expression changes between mice with NAFLD and healthy populations and then study 
the correlation between stiffness and gene expression. First the feasibility of the MRE to 
quantitate nonalcoholic steatohepatitis was investigated. The feasibility was proven by 
observing 40% increase (from 4.3 ± 0.7 kPa to 7.2 ± 1.0 kPa, P<0.02) in the mean 
stiffness of the liver tissue for the diseased mice after feeding them with the high fat diet 
food for four weeks. Furthermore, these results suggest a cutoff stiffness value 6.5 kPa 
which can be utilized in a diagnostic procedure and surveillance of NAFLD. Previous 
studies on liver fibrosis carried out on human and animal models presented different 
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stiffness values corresponding to similar stages of liver fibrosis. Early change of liver 
stiffness before appearance of liver fibrosis in animal models has been reported in 
previous studies [318-320]. In a similar study, Salameh et al. reported that mean elasticity 
of liver tissue increased nearly 23% (from 1.82 kPa ± 0.22 to 2.24 ± 0.19 kPa) in a well-
established NAFLD rat model after the week 2 while fibrosis is significantly increased 
after week 5. They reported the percentage of fibrosis increased from 1.4% ± 0.6 in the 
control group to 3.7% ± 1.5 at 5 weeks while remained nearly constant at week 2 (1.5% ± 
0.4). In another study, Yim et al. suggested a cutoff stiffness value of 1.61 kPa for 
hepatic liver fibrosis where their control groups have a mean shear stiffness value of 1.38 
± 0.20 kPa. Their results showed shear stiffness of fibrotic liver nearly increases 20% for 
3-month-old mice and 55% for 12-month-old. The type of actuator, lower vibration 
frequency (120 Hz), the extension of fibrosis, specimen type, and age, can be reasons of 
different measured values comparing to our study. In our study, the stiffness values of 
normal group also increased slightly in the course of the study which can be due to effect 
of age on liver tissue [320]. However, the significant alteration of the stiffness values in 
diseased cases, prior to the point that it is detectable by histology, confirms the reliability 
of noninvasive MRE scan compared with random liver biopsy. Several factors have been 
reported that are involved concurrently or in sequence in early increase of stiffness prior 
to myofibroblast activation (liver fibrosis is detectable after this point). Fibrogenesis 
markers like myofibroblast activation build up matrix stiffness and tightness [318, 319, 
321-323]. Other factors which can be found in literatures are inflammation [324], portal 
hypertension [325], and collagen cross-linking by members of the lysyl oxidase protein 
family [318]. 
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In addition, the results of our study showed the capability of MRE to evaluate and 
follow liver mRNA abundance of Glut4 and Igf1, as determined by real-time PCR 
analysis. mRNA abundance of Glut4 demonstrated a significant increase for high fat diet 
group at the end of the study. A slight increase in Igf1 mRNA was also observed. 
However, Tnfa, Sod1 and Sod2 mRNA expression didn’t change significantly between 
two populations. 
The gradient-echo and spin-echo based MRE sequences were developed and 
tested to obtain high quality and high SNR sufficient for post-processing algorithms. 
Since shorter echo time is inevitable to acquire higher MR signal in the liver tissue, 
gradient-echo based sequence which allows relatively shorter echo time worked better 
than spin-echo based sequence but still more SNR was required. This problem was solved 
by applying both cardiac and respiratory gating. Without the cardiac gating, a high 
quality and artifact-free GEMS image of the liver was not possible. In this study, in order 
to improve the functionality of applied gating system, the animal’s respiratory rate was 
maintained around 50 breaths per minute. This study was limited by the small number of 
specimens. Obviously, more animals are necessary to better correlate shear stiffness and 
gene expression with the different NAFLD stages. The designed actuator utilized a 
bending piezoelectric motor to generate transverse vibration. Further developments, 
especially using a stack actuator, are expected to create stronger motions that are 
adjustable to the patient's anatomy. 
7.5 Conclusion 
This study confirmed that MRE is able to noninvasively observe changes in the 
mechanical properties of the liver tissue such as stiffness and following that diagnose the 
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nonalcoholic fatty liver disease. Besides the liver stiffness, relative gene expression of 
Glut4, a fibrosis-specific marker, increased 4-fold at week 4. Knowing that no signs of 
obesity or fat were observed in both groups, the results of this research indicate that the 
expression of Glut4 and the noninvasively measured liver stiffness can both be used as 
reliable biomarkers for early detection of liver fibrosis in NAFLD subjects. This may 
suggest that the increase in liver stiffness is associated with increased expression of Glut4 
in NAFLD subjects; however, more investigation is recommended as a future direction 
using a larger number of animals. Later studies can be designed to correlate multiple MR-
based tools such as diffusion-weighted MRI, T1 and T2 relaxation maps, and MRE with 
the variations in liver gene expression for liver fibrosis detection. Moreover, attenuation 
of fibrosis in NAFLD treatment and its effects on gene expression and MRI-base data can 
be investigated. 
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CHAPTER 8 
 
SUMMARY AND OUTLOOK 
 
This dissertation is concerned with studying various applications of novel MRI 
technologies in tissue engineering and disease diagnosis, including the development of an 
MR-compatible incubation device capable of simultaneous culturing and imaging of cell 
growth under an autonomous in vitro stable controllable environment; the observation of 
bone tissue repair in a critical-sized calvarial defect model using MRI and near infrared 
optical imaging; characterization of imaging biomarkers for various tissue engineered 
cartilage constructs using MRI and MRE; and evaluation of the correlation between the 
liver stiffness and the liver genes expressions in nonalcoholic liver disease.  
8.1 The e-incubator system 
The aim of this study was to evaluate the design of a novel small-scale, portable, 
autonomous system, known as the e-incubator, which would enable real-time 
visualization of cultured tissue constructs or biological compounds in miniature sizes for 
different geometries and in a closed controlled environment. The design follows the need 
for a system with real-time tomographic imaging capability, which is enabled by 
integrating the platform with a high-field MRI system. All applied parts were designed 
and adapted to facilitate MRI imaging and to reduce MR signal loss.  
The e-incubator design provides a sterile environment, control over culture 
conditions (such as temperature, CO2 level, nutrient supply, waste drain, and growth 
factors), transparency to MR signal, accessibility of the culture for imaging, and 
media/gas reservoirs. Additionally, its chambers (including necessary components) 
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should be nonmagnetic and compact enough to readily fit inside the relatively narrow 
bore of most MRI micro-imaging systems; it should place the culture in the center of the 
field-of-view (FOV) while other parts can be outside of the scanner; it must be easily 
inserted in and out of the MR scanner. The e-incubator system can be easily tailored to 
any imaging system and can support multiple culture chambers, which allows for the 
culturing of several constructs. Prior to studies, culture conditions, growth factors, 
imaging schedule, harvesting time and implantation should all be planned. In a 
preliminary investigation various materials, electronics, sensors, mechanics, connections, 
biological materials and associated strategies are under examination to complete the final 
design. Mesenchymal stem cells seeded into a gelatin scaffold sponge are exploited to 
create a construct to produce bone. Through this examination we demonstrate the 
functionality of the system, maintenance of sterility, imaging access and MR 
characterization capability for the osteogenic construct within a four-week study. By 
continuous imaging of the culture with the MRI system, we will quantify its NMR 
parameters as the biomarkers for bone and will investigate the 3D structure of the 
construct during its growth. The purpose of this paper is to describe for the first time the 
design of the e-incubator system and demonstrate its functionality in a four-week 
osteogenic construct culture study. While the e-incubator system was used to engineer a 
bone tissue construct, it has the potential to be applied for versatile applications, 
particularly cancer treatment. 
The e-incubator was designed as a novel autonomous incubation system for long-
term cultures, enabling us to appropriately track the culture using medical imaging 
systems, here the magnetic resonance imaging. The obtained MRI images and 
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corresponding data represent the capability of the system to work as an in vivo mimicking 
environment that is observable in real-time by the imaging system. The viability test and 
bone formation approved by histology verified that the e-incubator can be efficiently used 
to produce human tissue-engineered bone. It also allows us to noninvasively measure the 
MR properties of the construct and finally harvest it without exposing it to contamination 
or any source of stress. This system has versatile potential applications in studies that 
need an environment that closely mimics required in vivo conditions, such as regenerative 
medicine, drug delivery, and pathophysiology of the diseases, in particular, cancer 
treatment. 
 The CO2/Air mixing system designed for this platform employs two mass flow 
controllers and a CO2 sensor. The sensor is employed to monitor and record the CO2 
concentration for calibration and alarming purposes. However, a feedback loop in the 
software of the gas/mixing system is missing and the current setup needs calibration 
based on the length of tubing and the capacity of the gas reservoir. Therefore, a feedback-
loop is required in order to remove the calibration phase and also to achieve more stable 
CO2 concentration.  
As the next step, we will transform the e-incubator into an MRI imaging-
compatible bioreactor by applying mechanical and electrical stimulations to the cultured 
construct which have been shown to deliver significant influences on the culture [326, 
327]. Furthermore, nesting mechanical actuators around the culture chamber will permit 
us to run the magnetic resonance elastography (MRE) experiments in order to measure 
the mechanical properties of the culture during growth [33, 311, 328]. These 
modifications might distort the homogeneity of the static magnetic field to such a degree 
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that an additional correction will be necessary through a modified pulse sequence [329, 
330]. Additionally, using a multiple-well sample holder, the e-incubator can be applied to 
study tumors by incubating tumor cells in one chamber and the target tissue in the other 
chamber. Moreover, contrast agents such as magnetic nanoparticles (iron oxide particles) 
can be used to improve the contrast in the MRI image [331]. By labeling the stem cells 
with these contrast agents, tracking the cells and their metabolism with MRI will be 
feasible for the system. It is shown that loading stem cells with iron oxide leads to 70 
times greater T2* sensitivity than for the T2-weighted images [332]. We combined the 
incubation system with the high field MRI system; however, it has the potential to be 
integrated with CT and PET imaging modalities, which can be studied in future projects. 
8.2 Monitoring bone repair in a mouse calvarial defect model using multimodal 
imaging 
The aim of this chapter was to determine the feasibility of multi-modal imaging 
techniques for observation of bone repair in a critical-sized calvarial defect mouse model. 
Five nude mice were subjected to two 5 mm calvarial critical non-healing defects. One 
site received an osteogenic silk construct after two weeks of in vitro culture and the other 
received a plain silk scaffold with no cells as control. After removal of sutures, the 
constructs were imaged using MRI and NIR optical imaging for monitoring the 
regeneration of tissue engineered osteogenic constructs. All MR images were gated to 
minimize blurring. Histological endpoint measurements and computed tomography (CT) 
were used to confirm imaging findings. Anatomical MRI revealed decreased signal 
intensity, indicating mineralization, in the TEB compared to the control, which is a plain 
silk scaffold with no cells, at various growth stages. Based on this study, MRI can 
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visualize mineralization but cannot differentiate ossified from calcified tissues. NIR 
optical imaging results demonstrated that the osteogenic construct exhibited an increased 
green fluorescence at month two compared to month one, while the control exhibited 
little to no fluorescence. This result confirms the specificity of NIR to mineralization in 
tissue-engineered bone. Taken together, these results demonstrate the potential of multi-
modal imaging to visualize and quantify tissue-engineered bone, which implies 
noninvasive techniques for assessment of regenerative medicine strategies. 
To improve results obtained from this feasibility study, it is necessary to verify 
and enhance the quality of TEB implanted into the defect model. Use of a spinner flask or 
a bioreactor for the pre-implantation culture can increase the quality of the tissue. 
Additionally, in order to provide an even distribution of hMSCs, improved seeding 
methods can be used for the silk scaffold dimensions rather than sectioning and 
implanting it immediately prior to surgery. Furthermore, it may be necessary to verify the 
quality of the TEB prior to surgery. Based on this study, fiduciary markers should be 
used to register images acquired via different modalities, and more comprehensive TEB 
evolution can be recorded. The same fiduciary markers can be used for the imaging 
modalities to help with replication of animal positioning as the animals grow.  
Future recommendations for this work also include characterizing the shear 
stiffness of the TEB using MRE during its growth. A mechanical actuator can be 
designed to generate mechanical waves propagating through the tissue constructs. The 
stiffness of the tissue-engineered bone can be quantitated and used as an early 
regeneration marker.  
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Also, images acquired via different modalities would be fused to provide 
comprehensive information on the development of engineered constructs. The aim of 
image fusion algorithms is to integrate complementary information from a multi-modal 
data set such that the fused images are more suitable for human and machine perception 
or further processing [333]. An approach based on intelligent algorithms such as fuzzy, 
neural network, wavelet, and genetic can be designed for multimodal medical image 
fusion. The resulting image would improve human visual perception and computer-
processing capabilities to achieve more comprehensive information of the engineered 
tissues in regenerative medicine. 
8.3 MRI-guided evaluation of cartilage tissue engineering in vivo 
In this chapter of this dissertation, work aimed to investigate the use of MRI and 
MRE for characterizing the growth of tissue-engineered cartilage in vivo. There is a great 
need for the development of a noninvasive method for observation of the composition, 
structure, and function of the tissue-engineered cartilage at different growth stages. MRI 
technologies possess a great potential to play a major role in evaluating tissue-engineered 
cartilage due to providing tomographic, high resolution images noninvasively and with 
various contrast mechanisms. Magnetic resonance elastography, a phase contrast MRI 
technique, measures shear stiffness of tissues with the use of mechanical vibrations, 
producing an acoustic wave which travels through the tissue. In this research, three types 
of scaffolds including silk, gelatin and collagen seeded by hMSCs were implanted 
subcutaneously in mice. The mice were imaged at 9.4 T using MRI and MRE to derive 
biological (transverse relaxation time T2) and mechanical (shear stiffness) during an 
eight-week in vivo study. At the end of the study, cartilage tissues were excised and 
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mRNA abundances of cartilage-specific genes were quantitated using the real-time 
polymerase chain reaction (qPCR). Altogether, the outcome of this research provides 
noninvasive, MRI-derived biomarkers for monitoring cartilage tissue growth after 
implantation and enables design of better engineered cartilage that can be translated into 
treatment of tissue defects.  
The biomarkers characterized in the current research will play a leading role in 
engineering cartilage and cartilage repair. Future recommendations for this work include 
fusing MRI magnitude images, stiffness maps, and transverse relaxation maps to give a 
comprehensive insight into the growth of cartilage. Also, the in vitro growth of the 
cartilage constructs cultured into the e-incubator system can be characterized using MRI 
and MRE. Then the constructs will be implanted in mice at multiple time points. The 
quality of resulting cartilage tissue will be monitored during their growth and compared 
with the biomarkers quantitated in this study. This will provide an optimal time for 
implanting the tissue construct after initial incubating.  
8.4 Assessment of nonalcoholic fatty liver disease using MRE and qPCR 
The aims of this study were first to develop quantitative biomarkers for diagnosis 
of nonalcoholic fatty liver disease as a potential alternative to biopsy using MRE and 
qPCR and then investigate the correlation between these biomarkers. Local stiffness 
alteration in tissues has been used by physicians to diagnose diseases through palpation. 
Over the last decade magnetic resonance elastography (MRE), a novel imaging modality, 
has been confirmed as a noninvasive, quantitative method for assessment of diseases 
through measuring the stiffness of body tissues. In this dissertation work, correlation of 
liver stiffness and fibrosis-specific genes expression in the evaluation of nonalcoholic 
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fatty liver disease was assessed. Two populations of mice, including one fed with a high 
fat diet and a control, were under study for four weeks. MRE measurements were 
performed at 9.4 T to map the liver tissue stiffness. The changes of liver genes expression 
between the two groups were also assessed at week four by transcription of mRNA 
followed by real time polymerase chain reaction. Physiologically, this suggests a rapid 
response of the liver to exposure to a high fat diet that may allow us to link liver tissue 
stiffness and the changes in the fibrosis-specific genes expression in the liver to better 
diagnose nonalcoholic fatty liver disease prior to the clinical onset of obesity. These 
validations and analyses are important steps in the continued development and translation 
of effective biomarkers of nonalcoholic fatty liver disease into clinical trials and as such, 
the correlation can assist in early detection and quantitative staging of NAFLD. 
Future studies should be conducted to identify the potential role of fibrosis-related 
genes in a larger population of animals for better statistics. Later studies can be designed 
to correlate multiple MR-based markers such as diffusion-weighted MRI, longitudinal 
relaxation T1 and transvers relaxation T2 and shear stiffness with the variations of liver 
gene expression for liver fibrosis detection. Moreover, attenuation of fibrosis in NAFLD 
treatment and its effects on gene expression and MRI-base data can be investigated. 
This study was to investigate early detection of NAFLD; therefore, it was 
conducted in four weeks. Future research could focus on longitudinal variations of liver 
stiffness measured for healthy liver, steatosis, steatohepatitis, and cirrhosis. Therefore, 
the association of liver stiffness and changes in the liver gene expression at the different 
levels of liver fibrosis can be investigated. 
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Also, MRI can be used in quantifying NAFLD in severe stages, and the results 
can be linked with liver stiffness and gene expression. The severity of steatosis can be 
assessed by MRI through chemical shift imaging. Studies showed that MRI is superior to 
other techniques such as ultrasound in detecting and quantifying minor degrees of fat 
accumulation in the liver [334]. 
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